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ABSTRACT
Following injury to the adult mammalian spinal cord, central nervous system (CNS) axons
do not spontaneously regenerate over significant distances. Recent attempts to facilitate the
regrowth of spinal cord axons have shown that following implantation of graft tissue or prosthetic
devices, severed CNS axons are capable of regrowing over significant distances.
The overall goal of our work is the development of a resorbable collagen-based tubular
implant to promote the regeneration of injured spinal cord axons. Previous research in this
laboratory has shown that a resorbable device, consisting of a collagen tube containing a highly
porous collagen-glycosaminoglycan (collagen-GAG) matrix, was capable of inducing regeneration
of peripheral nerves across a gap of 15 mm. In the current study, similar collagen-based devices
were implanted into 5-mm gap injuries in the spinal cords of adult rats.
A 5-mm gap was created in the spinal cord of adult Sprague-Dawley rats by performing
complete transections at T7 and T9 and removing the intervening spinal cord tissue. This gap
either remained unbridged or was bridged with a tubular implant of the type described below.
Resorbable collagen-GAG devices consisted of two components: a non-porous collagen tube
containing a specific collagen-GAG matrix, of known chemical composition and pore structure.
Four experimental implant groups were included in this study: Group I - no tube implant; Group
II - empty collagen tube; Group Ill - collagen tube containing collagen-GAG matrix of pore
diameter 95 gm; and Group IV - collagen tube containing collagen-GAG matrix of pore diameter
5 gim.
At 30 days, the gaps of group I animals were filled with fibrous scar tissue. In animals
receiving tubular implants (Groups II, III, and IV), a cable of reparative tissue was found within
the tube bridging the gap. Collagen tube implants were also found to modify the organization of
the glial scar at the injury site. Numerous myelinated axons had regrown into the tissue within the
gap in all groups.
These results demonstrate that collagen-based implants are capable of supporting the
regrowth of axons and facilitating other positive regenerative changes following spinal cord injury.
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CHAPTER 1: INTRODUCTION
1.1 Statement of the Problem
Severe injury to the adult mammalian spinal cord results in a loss of both sensory and
motor function below the injury site. Nerve fibers (axons) of the spinal cord which are severed by
injury exhibit only abortive regrowth and do not restore a connection with the original target. The
result is a permanent loss of function. An estimated 15,000 people per year suffer spinal cord
injury"5 . An estimated one million people currently live with deficits caused by a spinal cord
injury, and 500,000 people are currently designated as paraplegic or quadriplegic 5.
Current clinical treatments for spinal cord injury are successful in minimizing the severity
of the injury by suppressing the inflammatory response and immune reaction at the injury site.
However, these therapies are not effective in facilitating the repair of nerve fibers which were
injured by the initial injury. Current research in the field of spinal cord injury is attempting to solve
the problem of facilitating the regrowth or regeneration of injured nerve fibers, with the ultimate
goal of the return of function.
1.2 Normal Nervous System
Communication between the various parts of the body is carried out by the transmission of
electrical impulses by specialized cells of the nervous system called neurons. Neurons are capable
of receiving and sending signals. The neuron cell body (which contains the cell nucleus) is
responsible for the metabolic requirements of the cell and for receiving signals from a variety of
sources. These signals are processed and relayed via a long cell process of the neuron called an
axon (see figure 1.1 on the following page).
Figure 1.1. Neuron cell body and signal conduction along the axon.
Axons are often surrounded by a sheath of a lipoprotein called myelin which provides electrical
insulation increasing the speed of conduction of impulses. Myelin consists of tightly wrapped
layers of plasma membrane belonging to a myelinating cell. Myelinating cells of the peripheral
nervous system are called Schwann cells, and myelinating cells of the central nervous system are
called oligodendrocytes.
The nervous system consists of two general divisions: the peripheral nervous system
(PNS) and the central nervous system (CNS). The peripheral nervous system consists of bundles
of axons which carry impulses to and from the extremities of the body. These bundles of axons
make up peripheral nerves. The central nervous system consists of the neuron cell bodies and the
axons responsible for communication between neuron cell bodies. The central nervous system is
contained within the brain and the spinal cord. This project is primarily concerned with injury to
the central nervous system, particularly the spinal cord.
Figure 1.2 on the following page schematically depicts communication between the brain
and a skeletal muscle endpoint. A signal originates in a motor neuron within the brain and is
carried along an axon into the spinal cord where it forms a synapse with a second neuron. The
neuron within the spinal cord relays the signal along its axon within a peripheral nerve. The signal
terminates at a muscle endplate. The muscle is signaled to contract or relax.
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Figure 1.2. Normal nervous system communication.
The spinal cord contains four general cell types: neurons, oligodendrocytes, astrocytes, and
microglia. As discussed previously, neurons are the cells responsible for receiving, processing,
and sending signals. Oligodendrocytes are responsible for producing and maintaining the myelin
sheath of axons of the spinal cord. They are also seen in close association with unmyelinated
axons. Astrocytes basically fill the spaces between neurons and their processes. Astrocytes
provide physical support for the cellular elements of the nervous system and may also play a role in
nutrition and metabolic activities of neurons. Microglia are equivalent to the resident macrophages
of other tissue types. When stimulated by injury or infection, they express phagocytic activity.
Grossly, the spinal cord lies within the vertebral column descending from the brain for
approximately one half meter in the adult human5 . The vertebrae and ligaments provide mechanical
support and protection for the spinal cord. Additional protection is provided by the meninges,
which are the three layers of tissue which surround the spinal cord. The outermost layer, or dura
mater, consists of connective tissue and performs a mechanical and structural function. The inner
layers, the pia and the arachnoid, perform functions of maintaining the cerebrospinal fluid which
bathes the brain and the spinal cord. Two rows of nerve roots intermittently emerge on either side
of the spinal cord. These spinal nerves branch to form peripheral nerves which distribute motor
and sensory function to all parts of the body.
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Figure 1.3. Spinal cord and peripheral nerve roots (adapted from Heimer 199535).
1.3 Injury to the Nervous System
A mechanical injury to the nervous system disrupts intact axons and prevents the transfer of
signals, hence the loss of function below the injury site. When an axon has been transected, the
portion of the axon no longer attached to the cell body (distal to the lesion) becomes necrotic, and
is phagocytosed by macrophages. The myelin sheath which surrounded that axon also degrades
and is removed by macrophages. This process is known as Wallerian degeneration. Many
neurons die when their axons are transected, however a significant population of neurons survive
and are capable of regenerating an axon.
Peripheral Nervous System
Axons of the PNS show significant ability to spontaneously regenerate following injury.
Provided that the injury is small enough, peripheral nerve axons regrow and establish functional
connection. When an axon is severed, the neuron cell body undergoes changes in preparation for a
regenerative response. The cell body begins to produce nucleic acids structural proteins which
provide the building material for the regrowing axon. The tip of the axon at the site of transection
may branch into a number of sprouts, each with an enlarged tip called a growth cone. These
growth cones advance through the lesion site and may eventually form a function connection with
the original target.
r - - --- - - T --- ---
Neuron * Neuron IMuscle
.Muscle
I Brain I Spinal Cord I Injury
I Site II II
I
I
I
I
I Regrowing I '0 II .
Axon
t-Brain - - Spinal Cord r Peripheral Nerve
Central Nervous System Peripheral Nervous System
Figure 1.4. Injury and regeneration of the peripheral nervous system.
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In contrast to axons of the PNS, axons of the CNS show very little capacity to
spontaneously regenerate. An initial sprouting of axons growth cones is usually abortive. Under
normal conditions, severed axons of the CNS do not regrow and function is never restored.
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Figure 1.5. Injury to the central nervous system.
Cajal historically documented the aborttive regrowth of CNS axons in 192813. He hypothesized
that the lack of regeneration was not due to an intrinsic inability of CNS axons to regrow, but that
the environment a the site of CNS injury was not permissive for the regrowth of axons. More
recent studies have identified elements present at the site of CNS injury which act as barriers to
axons regeneration.
1.4 Barriers to CNS Regeneration
Two factors have been hypothesized to inhibit the regrowth of spinal cord axons: 1) the
formation of a dense fibrous scar within the wound site and 2) the formation of a continuous glial
scar encapsulating the injured spinal cord stumps 9 '13,32,46 65,79.
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Immediately following injury, the site of a wound is filled with blood. Macrophages from
blood sources begin to phagocytose debris and necrotic tissue. The wound soon becomes
infiltrated with fibroblasts invading from the non-neural tissue surrounding the spinal cord. These
cells form a connective tissue matrix which increases in density forming a fibrous scar between the
cut ends of the spinal cord. Numerous investigators have discovered that axons of the spinal cord
fail to regrow into or across the fibrous scar 3,24,42,79 . Fibrous scarring following spinal cord injury
is discussed in more detail in sections 3.1.4 and 4.1.3
Astrocytes become active in response to injury and extend their cytoplasmic processes into
regions of damage. The end result is the formation of a distinct partition between intact CNS tissue
and wounded tissue. This partition, known as the glial scar, is composed of a densely packed
network of reactive astrocyte processes. Two characteristics of the glial scar are implicated as
being responsible for blocking the regeneration of axons. It has been demonstrated in vitro that
reactive astrocytes characteristic of those in the glial scar do not provide a preferred environment
for axon elongation. The hypertrophy of astrocyte processes forms a dense network of processes
which axons do not preferentially cross 7'31' 39,51,7 9 . Astrocytes of the glial scar have been shown to
be responsible for forming a continuous layer of basement membrane (also known as the glial
limitans) encapsulating intact spinal cord tissue and blocking the progress of advancing axons29'43
The glial scar as an impediment to regeneration is also discussed in section 4.1.4.
1.5 Requirements for Successful Regeneration of the Spinal Cord
The endpoint of successful regeneration of the spinal cord is the return of function to areas
denervated by the injury. Function can be classified as either sensory or motor. The return of both
sensory and motor function is necessary. A return of function following injury to the spinal cord
would require the completion of three processes: 1) the sprouting and elongation of injured axons
from the wound site; 2) the regrowth of these axons eventually reaching their original endpoints;
and 3) the formation of functional connections (synapses). It is the work of the researcher to find
ways to facilitate these processes and to measure our success with applicable quantitative metrics.
The state of the art for treatment of spinal cord injury has not yet obtained complete
recovery, and success is usually measured in terms of the individual processes leading up to
functional recovery. The sprouting and regrowth of axons can be measured by histological
methods with which axons are identified. Neuroanatomical tracing methods can be used to identify
the path of regrowing axons determining whether these axons have regrown to their original
endpoints. Functional connections can be measured by observing the locomotion of the animal and
focusing on cues which correspond to reinervation of certain muscle groups or sensory regions.
Electrophysiological techniques test the ability of axons or nerves to carry an impulse to the target.
1.6 Progress Toward Spinal Cord Regeneration
Historically, Cajal confirmed that axons do not successfully regenerate following injury to
the spinal cord'". Cajal showed that spinal axons initially sprout and mount a regenerative
response, however any regrowth is abortive and digresses within two weeks. The research of
Windle and colleagues confirmed the observations of Cajal. Windle hypothesized that neurons of
the CNS were capable of regeneration, but the growth of axons was blocked by the presence of
glial and fibrous scar at the wound site24' 79 . As early as 1957, the use of a tube implant to
encourage the regeneration of spinal cord tissue was studied. A group lead by Campbell found that
axons were capable of regrowing within a nylon/millipore tube within the site of spinal cord injury
in the cat6."14 . However, functional recovery was not confirmed by any investigators.
Kao initially bridged spinal cord injuries of dogs with autologous grafts of sciatic nerve and
demonstrated the regrowth of axons into the grafts43. More recently, David and Aguayo
conclusively confirmed that axons of the CNS were able to regrow through segments of peripheral
nerve grafted into a gap lesion in the adult rat spinal cord26. Various other techniques have since
been used to encourage the regrowth of spinal cord axons. In 1986, Reier and colleagues
transplanted fetal spinal cord tissue into a spinal cord lesion in adult rats66. The transplanted tissue
became integrated with the host cord and supported the regrowth of axons, however, no functional
reconnection of axons was documented. Other investigators also observed similar results
following the transplantation of fetal tissue38'68
An alternative approach was taken by Schwab and his colleagues who identified specific
compounds in the spinal cord itself which inhibited the regrowth of axons 69. When the inhibitors
were neutralized using antibodies, axons were able to regrow over substantial distances10 .
The capacity of synthetic biomaterials to encourage axon regrowth following spinal cord
injury has been studied. In 1989, Houle and Johnson found that axons from peripheral sources
were able to regrow when strips of nitrocellulose treated with nerve growth factor were inserted
into the spinal cord37. Khan and colleagues discovered that carbon filaments provided an aligned
substrate which supported the regrowth of axons when implanted into spinal cord lesions45
Natural biomaterials, such as collagen have, also been evaluated for their ability to support the
regrowth of axons. DeLaTorre, Gelderd, and Marchand have studied the implantation of collagen
gels into spinal cord wounds 27' 30 '58
As mentioned previously, tubes have been used to bridge spinal cord lesions as early as
19576'14. More recently, Xu et. al. used blind-ended acrylonitrile/vinylchloride copolymer
(PAN/PVC) tubes as a vehicle for the delivery cultured cells into site of spinal cord injury81. CNS
axons were able to regrow into the tubes. Montgomery found that injured spinal cord axons were
able to regrow into polycarbonate tubes63. Fuctional recovery was not observed in any case.
Until recently, experimental treatments of complete spinal cord injury in adult mammals had
not resulted in a return of function. However, Cheng and colleagues recently observed that,
following treatment, experimental rats whose spinal cords had been completely transected were
able to bear weight with their hindlimbs22 . The return of function was seen only in rats which had
received multiple nerve grafts across the transection site held in place by fibrin glue containing
acidic fibroblast growth factor. This result is encouraging, since it demonstrates that axons which
regrow across spinal cord lesions are ultimately capable of restoring function
1.7 Previous Research in This Laboratory
A family of bioresorbable matrices composed of a collagen-glycosaminoglycan (collagen-
GAG) copolymer has been demonstrated to promote regenerative changes following injury to
several tissue types. Collagen-GAG matrix has been shown to induce the regeneration of a
physiologic dermis in the guinea pig84-87, 89 and human1 2' 34'71. Collagen-GAG matrix has also been
demonstrated to facilitate regeneration of a function meniscus in the dog following 80 percent
transection 4 .
Collagen-GAG matrix has also been shown to enhance the inherent regenerative capacity of
tissue of the peripheral nervous system. Axons were able to regrow across a 15-mm gap in the rat
sciatic nerve when the gap was bridged with a silicone tube containing collagen-GAG matrix"88 .
Axons did not regrow across the gap within empty tubes. The robustness of the regenerative
response was later found to depend on the chemical composition and pore structure of the matrix8 -
20. 53. In these studies, the collagen-GAG matrix was contained within a non-degradable silicone
tube implanted into the lesion site. Recent research suggests that the silicone tube may be replaced
by a completely resorbable collagen tube with an equivalent regenerative response'17 4 0 . These
resorbable devices, consisting of collagen tubes and collagen-GAG matrix, show promise for the
repair of damaged peripheral nerves in human patients.
The success of tubular implants containing collagen-GAG matrix in promoting the
regrowth of peripheral nerve axons suggests that a similar device may be capable of promoting the
regrowth of axons in the spinal cord.
1.8 Project Goal
The overall objective of this project is to develop a completely resorbable implant device
which promotes the regeneration of axons following spinal cord injury. The specific goal of the
work presented in this thesis was to examine the early healing response following injury to the rat
spinal cord and the effects of tubular implants on this healing process.
This study consisted of three parts, each discussed separately in chapters 2, 3, and 4. In
chapter 2, collagen-GAG matrix was prepared and its pore structure characterized. In chapter 3, an
animal model of spinal cord injury was established. In chapter 4, this animal model was used to
test the effects of various implant devices on spinal cord healing. The implant devices consisted of
collagen tubes which either remained empty or were filled with collagen-GAG matrix with a
specific pore structure.
CHAPTER 2: PREPARATION AND CHARACTERIZATION OF
COLLAGEN-GLYCOSAMINOGLYCAN MATRIX
2.1 Introduction
2.1.1 Previous Applications of Collagen-Glycosaminoglycan Matrix
As previously discussed in section 1.7, a family of porous collagen-glycosaminoglycan
matrix (CG matrix) implants has been shown to favorably alter the wound healing process
following injury to several tissue types. CG matrix is capable of facilitating partial regeneration of
the injured dermis in the guinea pig8487, 89 and human 12,3 4,7 1. Regeneration of the knee meniscus of
the greyhound was achieved following 80 percent transection and implantation of CG matrix7 4. A
functional rat sciatic nerve was found to regrow across a 15-mm gap in the presence of a CG
matrix implant"8 .
In the animal models for the study of dermal and peripheral nerve regeneration, studies
were performed in which CG matrices of different pore structure were compared in vivo 18,19, 25
For each tissue type, a CG matrix with specific pore structure yielded the most effective
regeneration. Therefore, one important factor which determines the effectiveness of CG matrix
implants in a specific injured tissue is its pore structure
One goal of the work described in this chapter was to determine the manufacturing
parameters required to produce collagen-GAG matrix implants for use in the spinal cord.
Particularly, two types of pore structure are of interest: 1) axially aligned pores of small diameter
(approximately 5 im), and 2) axially aligned pores of large diameter (approximately 100 gm).
2.1.2 Theory of Freeze-Drying Fabrication of CG Matrix
Collagen-glycosaminoglycan matrix implants are manufactured in this laboratory by a
freeze-drying process comprising multiple steps: 1) a copolymer of type I collagen and chondroitin
6-sulfate is formed as a suspension in dilute (0.05M) acetic acid; 2) the suspension is frozen,
forming ice dendrites; 3) the ice dendrites are removed by freeze-drying leaving a porous network
of collagen-GAG copolymer and void spaces in place of the sublimed ice; 4) dehydrothermal
treating the collagen-GAG network to form covalent crosslinks between polymer chains.
CG matrix implants for a particular application (dermis, nerve, meniscus) require a
geometric shape to match the form of the tissue being studied. Since skin is thin and flat, CG
matrix implants for replacement of injured dermis are fabricated in sheets 2-mm thick. In the rat,
the sciatic nerve takes the form of a long cylinder 1.5 mm in diameter. Implants for nerve are
fabricated as hollow cylinder-shaped segments 1.5 mm in diameter. The thoracic spinal cord of the
adult rat is cylindrical having a diameter of 3.0 mm. CG matrix implants for the spinal cord need
to be cylindrical and 3.0 mm in diameter, twice the diameter of sciatic nerve implants.
1.5 mm
2 mm
Collagen-GAG matrix sheets used for
dermal regeneration in guinea pig model
Cylindrical collagen-GAG matrix used for
sciatic nerve regeneration in rat model
Figure 2.1. Collagen-GAG matrix implants for skin and peripheral nerve
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Figure 2.2. Schematic of collagen-GAG implant in the injured spinal cord.
Flat sheets are produced by pouring collagen-GAG suspension into an aluminum tray. The
temperature is lowered, and the shallow pool freezes. The frozen sheet is freeze-dried to form a
thin flat sheet of CG matrix. Cylindrical specimens are formed by lowering a tube filled with
collagen-GAG suspension into a low-temperature bath. The freezing front travels axially within
the tube forming ice dendrites elongated parallel to the axis of the tube. During freeze-drying, the
ice dendrites are removed by sublimation to create pores which are also aligned axially.
The relationship between manufacturing parameters and pore structure has been previously
established for flat sheets of CG matrix21. The freeze-drying of CG matrix cylinders 1.5 mm in
diameter has also been studied in detail52. Most recently, Louie studied the manufacture of CG
matrix cylinders 3.8 mm in diameter54. The size and orientation of pores in the CG matrix is
determined by the size and orientation of the ice dendrites which form during the freezing process.
In general, lower freezing temperatures produce smaller pores, and higher temperatures produce
larger pores. The work of Loree52 demonstrated that in cylindrical CG matrix, not only can pore
size be controlled by freezing temperature, but the pores can be aligned along the cylinder axis by
Collagen-GAG
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Tube
lowering the tube of collagen-GAG suspension into a cooling bath at different velocities. The
degree of pore alignment depends on the coupling of freezing temperature and lowering velocity.
In all previous studies of pore structure of CG matrix21.41.52,54, the CG matrix was prepared
using collagen provided by the United States Department of Agriculture (USDA, Philadelphia,
PA). Specifically, USDA collagen is insoluble type I collagen extracted and refined from bovine
hide. For the experiments discussed in this chapter, CG matrix was produced using insoluble type
I bovine achilles tendon collagen provided by Integra LifeSciences Corporation (Plainsboro, NJ).
There may exist subtle differences between CG matrix produced using USDA bovine hide collagen
and CG matrix produced using Integra bovine tendon collagen. A primary goal of the work
presented in this chapter is to manufacture CG matrix using Integra tendon collagen and to compare
its pore structure with the previously studied pore structure of CG matrix produced using USDA
hide collagen.
2.1.3 Objectives of Work in this Chapter
The goal of work presented in this chapter was to establish general relationships between
manufacturing parameters and pore structure of CG matrix. This work differed from similar
previous studies in two respects: the collagen source for these experiments was Integra bovine
tendon rather than USDA bovine hide, and the geometry of spinal cord implants is a 3.0-mm
diameter cylinder (1.5-mm and 3.8-mm diameter CG matrices were previously studied).
Two types of CG matrix are desirable for study as spinal cord implants: CG matrix with
axially aligned pores of small diameter (approximately 5 gm), and CG matrix with axially aligned
pores of large diameter (approximately 100 tm). The second goal of this research was to
determine the manufacturing parameters required to produce these particular matrices.
2.2 Materials and Methods
2.2.1 Preparation of Collagen-glycosaminoglycan Matrix
The process for preparing collagen-GAG spinal cord implants is derived from previously
established protocols for implants for peripheral nerve 52. The process involves four basic steps: 1)
forming a suspension of collagen-chondroitin 6-sulfate copolymer in dilute (0.05M) acetic acid; 2)
freezing the collagen-GAG suspension by lowering into a bath of low-temperature coolant; 3)
freeze-drying the solid suspension to form a highly porous network of collagen-GAG fibers; 4)
dehydrating the porous collagen-GAG at elevated temperature and under vacuum to form covalent
crosslinks between polymer chains. Detailed protocols for each of these procedures is included in
appendix A.
The collagen component of collagen-GAG matrix is insoluble type I collagen derived from
bovine achilles tendon (Integra LifeSciences Corp., Plainsborough, NJ). Chondroitin 6-sulfate is
available as a white crystalline powder (product C-4383, Sigma Chemical, St. Louis, MO). To
prepare collagen-GAG suspension, 13.69 g of Integra collagen was weighed and pulled into small
pieces using forceps. The collagen pieces were added to 600 ml of 0.05 M acetic acid maintained
at 4oC in an overhead blender (Granco overhead blender, Granco Co., Kansas City, MO,
Brinkman cooler model RC-3T, Brinkman Co., Westbury, NY). This mixture was blended at
2000 rpm while cooled at 40C for 90 minutes. 0.32 g of chondroitin 6-sulfate was weighed and
dissolved in 120 ml of 0.05 M acetic acid. The chondroitin 6-sulfate solution was added to the 600
ml of blended collagen over 15 minutes using a peristaltic pump (Manostat cassette pump,
Manostat, New York, NY). Blending was continued during the addition of the chondroitin 6-
sulfate solution. The mixture of collagen and chondroitin 6-sulfate was blended at 4oC for an
additional 90 minutes at 2000 rpm. During blending, a coprecipitate of collagen and chondroitin 6-
sulfate was formed which remains in suspension in the dilute acetic acid. The blended suspension
was degassed for 15 minutes in a 6 liter vacuum flask.
Using a 3-ml syringe (Becton Dickenson & Co., Rutherford NJ) degassed collagen-GAG
suspension was injected into the open end of a 10 cm length of silicone tubing (ID, 5/32 inch, OD,
7/32 inch, Cole Parmer, Niles IL) in preparation for freezing. An insulating sleeve of PVC (ID, 6
mm, OD, 9 mm, Cole Parmer, Niles IL) was slipped over the length of the tube. After filling with
CG suspension, the ends of the silicone tube were clamped. A diagram of the clamped silicone
tube (containing collagen-GAG suspension), PVC sleeve, and surface of cooling bath is shown in
Figure 2.3. The PVC sleeve, silicone tube, and CG suspension inside were lowered axially into a
bath containing a silicone-based coolant (Syltherm XLT Heat Transfer Liquid, Dow Corning
Corp., Midland MI). The coolant bath was maintained at any desired temperature between -10oC
and -80oC.
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Figure 2.3. Collagen-GAG suspension contained within silicone tube and PVC sleeve
The velocity at which the tubing and collagen-GAG suspension were lowered into the
coolant bath was controlled within the range between 2x10 -5 m/s and 10x 10- m/s. One end of the
silicone tube was connected to a vertically hanging cord which was attached to a 1/30 RPM timing
motor (Cramer model 117P, Conrac Co., Old Saybrook, CT). By changing the size of the gear on
the motor (Berg model GG33S14-12, GGS14-30, GGS14-64, Winfred M. Berg Inc., East
Rockaway, NY), the velocity at which the suspension was lowered could be controlled. A
schematic diagram of the complete freezing bath and lowering apparatus 52 is shown in Figure 2.4.
Once the suspension had completely lowered into the bath and was submerged, it remained in the
bath for approximately 30-60 minutes to ensure complete solidification.
Figure 2.4. Schematic diagram of Loree 2000 freezing apparatus (adapted from Loree5 2).
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In this experiment, two parameters were varied independently: 1) the temperature of the
cooling bath, and 2) the velocity at which the collagen-GAG suspension was lowered into the
cooling bath. Three cooling bath temperatures were used: -10OC, -45oC , and -800C. At each
temperature, three lowering velocities were used: 2x10 5- m/s, 5x105- m/s, and 10x10 5 m/s. This
gives a total of nine groups matching each temperature with one of three lowering velocities.
As the suspension was lowering into the cooling bath, the VirTis freeze-drying apparatus
(VirTis Genesis, VirTis, Gardiner, NY) and one aluminum tray were cooled and allowed to
equilibrate to -30'C. The pre-cooled aluminum tray served as a cold surface on which the
following procedure was performed. While frozen solid, the 10-cm length of silicone tube and CG
suspension was cut using a razor blade into 2.5-cm segments. The segments at each end of the
tube (nearest the clamps) were discarded, and the segments in the middle of the tube were retained
for freeze-drying.
The segments of frozen CG suspension were placed horizontally on the pre-cooled
aluminum tray, and the tray was placed in the FTS freeze-dryer chamber. The freeze-dryer was
again allowed to equilibrate to -300 C. A vacuum of 100 mtorr was pulled in the chamber which
was maintained at -300C. Under vacuum of 100 mtorr, the temperature of the chamber was raised
to O0C and held for 24 hours. At this low pressure and elevated temperature, the ice crystals within
the CG suspension were sublimed, leaving a porous network of collagen-GAG copolymer.
Following complete sublimation, the temperature of the chamber was raised to 22oC and held for
an additional 45 to 90 minutes to equilibrate to room temperature. The vacuum was released, and
the dry CG matrix segments were removed.
The freeze-dried CG matrix was ready for dehydrothermal (DHT) treatment. Each segment
of matrix was placed in an open-ended packet made of aluminum foil. These packets were placed
in a vacuum oven (Fisher Isotemp vacuum oven, Fisher Scientific, Medford, MA). A vacuum of
30 mmHg was pulled, and the temperature was raised to 105'C for 24 hours. As the packets were
removed from the oven, the open end was sealed. The sealed packets containing CG matrix were
stored in a desiccating chamber. DHT treatment served two purposes: 1) to effectively sterilize the
CG matrix implants, and 2) to form covalent crosslinks between collagen-GAG copolymer
chains 82.
2.2.2 Characterization of Pore Structure of Collagen-Glycosaminoglycan Matrix
Previously, the relationship between manufacturing parameters and pore structure of
axially frozen CG matrix segments has been examined5 2' 5 4. The particular manufacturing
parameters of interest are: 1)cooling bath temperature, and 2) the velocity at which CG suspension
was lowered into the cooling bath. Pore structure has been characterized and described by
numerous features, among them average pore diameter and pore channel orientation. In this
experiment, average pore diameter was measured quantitatively, and pore channel orientation was
assessed qualitatively.
Microscopic examination of CG matrix samples was performed using an environmental
scanning electron microscope (ESEM, Electroscan, Waltham, MA). The collagen-GAG matrix
samples do not conduct charge well. In order to view CG matrix samples in the SEM, they would
need to be sputter coated with a conducting material such as gold. Viewing with ESEM has the
advantage over conventional SEM since the samples do not need to be coated. Coating with gold
could alter the fine porous structure of the matrix.
In preparation for ESEM viewing, samples of CG matrix were cut transversely with a razor
blade into 3-mm thick wafers and mounted onto SEM stubs with two-sided conductive tape.
Segments of matrix were also cut longitudinally to observe pore channel orientation. ESEM
micrographs were developed on thermal paper (Mitsubishi, Japan) and on instant photographic
film (Polaroid Corporation, Cambridge, MA). Each image contained its own scale bar, allowing
for later calibration of pore size measurements. These images were used as follows to examine
pore structure.
Thermal prints of each ESEM micrograph were converted to TIFF format computer files
using a laser scanner (UMAX model UC1260, UMAX Data Systems Inc., Industrial Park,
Hsinchu, Taiwan, Republic of China). The TIFF images were imported into a computer
stereology package (NIH Image, available via internet FTP from zippy.nimh.gov or on disk from
NTIS, 5285 Port Royal Road, Springfield, VA 22161 part no. PB 93-504868). The size scale of
each image was defined using the ESEM scale bar and the measured on-screen distance in pixels.
Each image had a slightly different size conversion due to the changing magnification of the
ESEM.
Following calibration, individual pores present in the image were outlined using the
computer mouse. The NIH image software contains an automated process which measures the
area of each circled pore as well as the length of the perimeter of each pore. The software also
numbers and counts each pore. Since the pores are not exactly circular in shape, a true circular
diameter cannot be measured. The following equation defines an equivalent or hydraulic diameter
of each pore:
4*ADh pore
pore
where Dh is the equivalent hydraulic diameter of the pore in jtm, Apore is the measured area of the
pore in gm2, and Ppore is the measured perimeter of the pore in gm. The hydraulic diameter is
defined as the diameter of an exact circle having the same cross sectional area as the pore in
question. Thus yielding an equivalent diameter for a non-circular shape. Figure 2.5a on the
following page shows an ESEM micrograph of the porous structure of CG matrix. Figure 2.5b
shows the same image following analysis with NIH Image software. A number of individual pores
are shown selected and analyzed.
Figure 2.5a. ESEM image of CG matrix Figure 2.5b. Image with analyzed pores.
before analysis.
ESEM micrographs of longitudinally cut CG matrix specimens were evaluated qualitatively
for alignment of pore channels. Pore channel orientation was categorized as 1) axial aligned, 2)
radial aligned, or 3) no apparent orientation.
2.3 Results
2.3.1 Average Pore Diameter
The quantitative results for pore diameter measurement are shown in Table 2.1 on the
following page. The grid contains the nine combinations of cooling bath temperature and lowering
velocity. For each combination of freezing temperature and lowering velocity, three ESEM images
were analyzed and the pore size measured. Each result is presented as the mean +/- standard
deviation based on three samples.
lOxlO-5 m/s
5x10 5 mn/s
2x 10-5 m/s
Cooling
-800C
Bath Temperature
(Celsius)
-45oC -100C
Table 2.1. Measured pore size for combinations of cooling
bath temperature and lowering velocity
These results show that cylindrical CG matrices with pore diameters ranging between 5.48 tm and
152 gm can be produced by the axial freezing process. The smallest average pores (5.48 gm
diameter) resulted from a freezing bath temperature of -80'C and a lowering velocity of 10x 10-5
m/s. The largest average pores (152 gm) resulted from a freezing bath temperature of -10'C and a
lowering velocity of 10x10- m/s. In general, higher temperatures yielded larger pores, and lower
temperatures yielded smaller pores.
Below are shown sample SEM micrographs from CG matrix with relatively large and
relatively small pores. The sample in Figure 2.6a was produced with a cooling bath temperature of
-10oC and a lowering velocity of 10x10 5 mrn/s. The sample in Figure 2.6b was produced with a
cooling bath temperature of -800C and a lowering velocity of lOx 100 m/s. Note that the two
images have different magnification.
0
0,
0r
-4
5.48 +/- 9.96 +/- 152 +/-
1.1 gm 0.64 gm 26.6 gm
12.3 +/- 10.5 +/- 88.7 +/-
2.6 gm 3.3 gm 4.4 gm
41.3 +/- 41.3 +/- 93.1 +/-
4.8 gm 3.4 gm 7.2 gm
Figure 2.6a. ESEM image of CG matrix Figure 2.6b. ESEM image of CG Matrix
with large pores. with small pores.
2.3.2 Pore Channel Orientation
For the pore diameter analysis presented in the previous section, cylindrical CG matrix
samples were viewed with ESEM in a direction along the long axis of the cylinder. To assess pore
channel orientation, CG matrix samples were viewed with the ESEM longitudinally (i.e., cut in a
direction perpendicular to the long axis of the cylinder). For each group of CG matrix samples
produced with a particular combination of cooling bath temperature and lowering velocity, pore
channel orientation was qualitatively categorized as 1) axially aligned, 2) radially aligned, or 3) no
noticeable orientation. Table 2.2 on the following page summarizes pore orientation observations
for the nine combinations of cooling bath temperature and lowering velocity.
10x10 mi/s
5x10 5 m/s
2x10-5 m/s
Cooling Bath Temperature
(Celsius)
-800C -45 C -101'C
Axially No Noticeable No Noticeable
Aligned Orientation Orientation
Axially Axially Slight Radial
Aligned Aligned Orientation
Axially Axially Axially
Aligned Aligned Aligned
Table 2.2. Pore orientation for different combinations of
cooling bath temperature and lowering velocity
Table 2.2 illustrates the fact that cylindrical CG matrix can be produced with pores aligned parallel
to the long axis of the cylinder. In most cases, the pores themselves were not elongated in a
direction parallel to the long axis of the cylinder, but columns of pores form distinct channels
which were aligned parallel to the long axis of the cylinder. An example of pore channels with
random orientation is shown in Figure 2.7a below, and pore channels with axial alignment were
shown in Figure 2.7b.
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Figure 2.7a. ESEM image of CG matrix with Figure 2.7b. ESEM image of CG Matrix
random pore channel orientation. with axially aligned pore
channels.
2.4 Discussion
2.4.1 Effect of Cooling Bath Temperature on Pore Size and Pore Channel
Orientation
The chart in Figure 2.8 on the following page illustrates the effect of cooling bath
temperature on average pore size. In general, the larger pore sizes were produced using higher
cooling bath temperatures. Smaller pore sizes result from lower temperatures.
Average Pore Diameter vs Cooling Bath Temperatu
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Figure 2.8. Chart illustrating the relationship between average pore diameter
and cooling bath temperature for three lowering velocities.
The effect of cooling bath temperature on average pore size becomes more apparent at higher
cooling bath temperatures. There was very little change in pore size with a change in cooling bath
temperature from-800C and -450C (pore diameter changes from 19.7 gm to 20.6 gm averaged
based on three levels of lowering velocity). However, there was a larger change in pore size
cooling bath temperature was changed from -45oC to -10oC (pore diameter changes from 20.6 gm
to 111.3 gm averaged across three lowering velocities).
With reference to Table 2.2, pore channel orientation tends to change from axially aligned
to slightly radially aligned or no noticeable orientation with increasing cooling bath temperature.
However, with the lowering velocity of 2x10-5 m/s, pore channels were axially aligned regardless
of cooling bath temperature.
""~"'
2.4.2 Effect of Lowering Velocity on Pore Size and Pore Channel Orientation
The chart in Figure 2.9 below illustrates the effect of lowering velocity on average pore
size. The general trend was a decrease in pore diameter as the lowering velocity was changed from
2x10 5 m/s to 5x10 -5 r/s (pore size decreases from 55.8 im to 37.2 gm averaged across three
cooling bath temperatures). However, as lowering velocity was changed from 5x10-5 m/s and
10xl0O m/s there were mixed results; pore size increases when the cooling bath temperature was -
100C and decreases when the cooling bath temperature was -45oC or -80'C.
Average Pore Diameter vs Lowering Velocity f
Various Cooling Bath Temperatures
Cooling Bath
Temperature
(Celsius)
-0---80
--- -45
-- 10
O.OOE+00 2.00E-05 4.00E-05 6.00E-05 8.00E-05 1.00E-04 1.20E-04
Lowering Velocity (m/s)
Figure 2.9. Chart illustrating the relationship between average pore diameter
and lowering velocity for three cooling bath temperatures.
Referring to Table 2.2, increasing the lowering velocity tends to change pore channel orientation
from axially aligned to slightly radially aligned or no noticeable orientation. However, with a
cooling bath temperature of -80oC, pore channels were axially aligned with all lowering velocities
(2x10 5- m/s, 5x10 5- m/s, and 10x10-' m/s).
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2.4.3 Comparison to Previous Results
The relationship between manufacturing parameters and resulting pore structure of
cylindrical CG matrix has been previously studied in this lab by Loree and Louie 52'54. The
conditions for the present study and those for previous studies differed in two respects. First, the
source for collagen in previous experiments was USDA bovine hide, while the present study used
Integra bovine tendon collagen. Second, the diameter of Loree's CG matrix was 1.5 mm, and the
diameter of Louie's matrix was 3.8 mm. The diameter of CG matrix in this experiment was 3.0
mm. Loree and Louie separately established that for cylindrical CG matrix, there are two general
links between manufacturing parameters and pore structure. Lower cooling bath temperatures
result in small pores while higher temperatures result in larger pores. And, only certain
combinations of cooling bath temperature and lowering velocity result in axially aligned pore
channels. Despite the differences in source collagen and cylinder diameter, the results of this
experiment agree with the findings of Loree and Louie.
Both Loree and Louie also found that certain combinations of cooling bath temperature and
lowering velocity resulted in CG matrix with radially aligned pores. In this experiment, only one
combination of temperature and velocity (-10oC and 5x 10-5 m/s) resulted in pores with only a slight
radial orientation.
2.5 Conclusions
Cylindrical specimens of CG matrix 3.0 mm in diameter were produced with pore size
ranging between approximately 5 and 100 gm. With specific combinations of cooling bath
temperature and lowering velocity, pore channels were aligned axially, aligned radially, or without
noticeable orientation. To summarize the effects of cooling bath temperature on pore size and pore
channel orientation: 1) an increase in cooling bath temperature tended to produce CG matrix with
larger pores, and 2) pore channel orientation tended to be less axially aligned as cooling bath
temperature was increased. To summarize the effects of lowering velocity on pore size and pore
channel orientation: 1) an increase in lowering velocity had mixed effects on average pore size
depending on the cooling bath temperature, and 2) with respect to pore channel orientation, higher
lowering velocities tended to form pore channels which were less axially aligned.
CG matrices of two specific pore geometries are desirable for use as spinal cord implants.
CG matrix with small pores (average 5.48 gm diameter) and axially aligned pore channels was
produced with a cooling bath temperature of -800C and a lowering velocity of 10x 10-5 m/s. CG
matrix with large pores (average 93.1 gtm in diameter) and axially aligned pore channels was
produced with a cooling bath temperature of -10OC and a lowering velocity of 2x 10-5 m/s.
CHAPTER 3: COMPARISON OF ANIMAL MODELS OF
SPINAL CORD INJURY
3.1 Introduction
The overall goal of this project was to study the effect of collagen-based tubular implants
on spinal cord healing. The specific focus of this chapter was the establishment of an animal
model of spinal cord injury in which the effects of tubular implants can be evaluated.
3.1.1 Animal Models of Spinal Cord Injury
Numerous animal models have been used for the study of healing following spinal cord
injury. The most common experimental animal is the rat, and this chapter will be focused on rat
models. The most simple method of injuring the spinal cord is to impose damage to the spinal cord
tissue by use of various mechanical devices. A number of methods have been used to cause
damage. A blunt impact, which is referred to as contusion, is usually applied by dropping a
weighted piston directly onto the spinal cord. This injury model has been characterized and used
by several investigators8'73 ,76' 80 . An injury may also be created by crushing the spinal cord tissue
using forceps. This injury type is referred to as compression and has been studied by other
groups33,61,75 . It is important to note that after contusion and compression injuries, although the
spinal cord has been damaged, a geometrically continuous cord of necrotic tissue remains intact in
the lesion site. A schematic of contusion and compression injuries is shown in figure 3.1 on the
following page.
Figure 3.1. (a) Contusion and (b) compression spinal cord injury models.
Other methods of injuring the spinal cord involve directly severing the spinal cord tissue
using a surgical blade. A surgical lesion may disrupt part of the spinal cord (partial transection or
hemisection) or the entire spinal cord (complete transection). A hemisection model in which half of
the spinal cord is cut has been used by many groups 1' 36'63'68. A complete transection model has
been used by other investigators2 9' 45,59. Another alternative surgical model of spinal cord injury is
the complete transection of the cord with the subsequent removal of a length of spinal cord tissue.
This type of injury is often referred to as a gap injury, since a segment of tissue has been
completely removed. This model has been used in other laboratories28 '30 ' 57' 67'81 . Figure 3.2 on the
following page shows schematics of (a) hemisection, (b) complete transection, and (c) gap surgical
lesions. For reference, the diameter of the rat spinal cord (approximately 3 mm) is shown.
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Figure 3.2. (a) Hemisection, (b) complete transection, and (c) gap lesions.
One goal of the research presented in this chapter was to compare different surgical models
of spinal cord injury, specifically the hemisection, complete transection, and gap, from the
viewpoint of the desired study of the effect of tubular implants on healing.
3.1.2 Device Implantation
Contusion and compression models closely simulate spinal cord injuries seen in human
patients. However, since the tissue is crushed and not severed, injured spinal cord tissue remains
at the injury site. The presence of injured tissue hinders the possible insertion of a graft or a device
into the wound. For this reason, contusion or compression injury types were ruled out as
possible models in which a tubular implant could be studied.
Surgical lesions (hemisection, complete transection, and gap) are more conducive to the use
of implants since a space is created into which a device can be implanted. Hemisection and
complete transection lesions create a narrow opening into which a thin disc-shaped implant can be
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inserted (figure 3.3a and 3.3b). Gap injuries create a larger cavity into which a tubular implant can
be inserted (figure 3.3c). Approximate dimensions are given for scale.
Figure 3.3. Implants for (a) hemisection, (b) complete transection, and (c) gap lesions.
A surgical lesion must be reproduced from one animal to the next. If a hemisection is
performed, it is important that 50 percent of the tissue is severed consistently. If a complete
transection is performed, it is important that the entire spinal cord is cut, since any tissue that
remains intact in the wound site may be later mistaken as regenerated tissue. One purpose of the
work presented in this chapter was to determine if spinal cord lesions can be reproducibly created
and if it is feasible to deliver an implant device into such lesions.
3.1.3 Effects of Spinal Cord Injury on Animal Survival
Trauma to the mammalian spinal cord causes short and long-term physiological deficits.
Animals temporarily lose reflex bladder function and lose voluntary motor function below the
lesion site. The initial trauma as well as the resulting deficits often result in death. Different lesion
types may inflict more or less trauma and result in a higher or lower post-operative mortality rate.
In choosing a surgical lesion, one important factor is the resulting animal death rate. For a useful
lesion, an acceptable number of animals, of order of 50 percent, must survive to the end of a study
period of at least 30 days.
3.1.4 Isolation of Spinal Cord Wounds from Adjacent Non-Neuronal Tissue
The invasion of dense fibrous scar tissue into spinal cord wounds has been shown to be an
impediment to favorable healing and a barrier to the regrowth of axons33,46,48,59. Previous
investigators have placed synthetic membranes over the dorsal aspect of the wound site as barriers
to fibrous scar migrating into the wound from injured muscle tissue3 6,4 8,68'81. These synthetic
membranes are effective in restricting invasion of scar tissue, but they are not resorbable and
therefore would remain permanently in the wound site. A thin, non-porous, biodegradable
collagen-GAG (CG) membrane, produced in this laboratory and referred to below as a CG dorsal
barrier, was used to prevent invasion of scar from the wounded muscle tissue immediately adjacent
to the injured cord.
3.1.5 Objectives of Work in this Chapter
To summarize, the general goal of the work described in this chapter was to compare
different lesion types with the purpose of establishing an animal model for the study of spinal cord.
Hemisection, complete transection, and gap lesions were studied with or without the addition of a
CG dorsal barrier. The following parameters for a satisfactory animal model were assessed in this
study: 1) satisfactory animal survival and maintenance; 2) animal-to-animal reproducibility of the
lesion; and 3) feasibility of implantation of test devices.
3.2 Materials and Methods
3.2.1 Experimental Groups
The specific aims of the research discussed in this chapter are two fold. First, three
surgical injuries to the rat spinal cord were compared (hemisection, complete transection, and gap).
Second, the effectiveness of a non-porous CG dorsal barrier in reducing the ingrowth of fibrous
scar tissue was studied. With this purpose, a total of 25 experimental animals were grouped as
shown in Table 3.1. Animals were allowed to survive for 5 weeks.
Table 3.1. Experimental Groups
3.2.2 Preparation of CG Dorsal Barrier
The CG dorsal barrier was manufactured from the collagen-GAG suspension described in
the previous chapter (section 2.2.1). A detailed protocol for preparation of the suspension is
located in appendix A. The suspension was degassed for 15 minutes in a 6-liter vacuum flask
attached to a vacuum pump at 30 mm Hg. The degassed suspension was poured into a shallow
Surgical CG Dorsal Barrier
Lesion A. No B. Yes
I. Hemi- Group IA Group IB
section n=4 n=4
II. Complete Group IIA Group IIBTransection n=6 n=5
III. 6-mm Group IIIA Group IIIB
Gap n=3 n=3
plastic weigh boat, (Catalog #12577-027, VWR Scientific, Boston, MA) taking care not to create
bubbles as the suspension was poured. To produce a collagen membrane 0.005" thick, 3.5 ml of
collagen-GAG suspension was poured for every square centimeter of weigh boat area. The
collagen-GAG suspension contained in the weigh boat was placed in the laminar flow hood
(Sterigard Hood, Model #VBM-400, The Baker Company Inc., Sanford, ME) to evaporate at
room temperature in the absence of airborne particles. Following evaporation and drying, the
shallow pool of suspension was transformed to a thin, non-porous membrane. Drying was
complete in 72 hours. In preparation for dehydrothermal (DHT) treatment, the CG dorsal barrier
was placed in packets made from aluminum foil. Each packet was placed in a vacuum oven
(Fisher Isotemp vacuum oven, Fisher Scientific, Medford, MA) for 24 hours at a vacuum of 30
mm Hg and a temperature of 105TC. DHT treatment effectively sterilizes the collagen-GAG film,
and produces covalent crosslinks between polymer chains"2. Care must be taken to expose the film
to temperature of 105'C only after the moisture content of the film has been previously reduced
below 10 weight-percent in order to prevent melting of the collagen triple helix to gelation at this
temperature level"3.
Sterile rectangles of CG dorsal barrier 12 mm x 8 mm were prepared for surgery in a
laminar flow hood (Relialab, Tenney Engineering Inc., Union, NJ) using sterile gloves, gown,
mask, and instruments. A detailed protocol for sterile CG dorsal barrier preparation is located in
appendix A. Rectangular segments of dry membrane 12 mm x 8 mm were cut using sterilized
scissors and forceps. Each segment was immersed briefly in sterile 100 percent ethanol followed
by two rinses in sterile phosphate buffered saline (PBS mix packets, Sigma, St. Louis, MO).
Segments of collagen-GAG membrane were placed in sterile glass vials containing sterile PBS.
Bottles were maintained sterile until surgery by storage in sealed sterile bags (Sterile Sampling
Bags, Fisher Scientific, Pittsburgh, PA).
3.2.3 Surgical Procedure and Post-operative Care
The animals used in this experiment were adult female Sprague-Dawley rats weighing 250-
350 grams (Taconic, Germantown, NY). Rats were anesthetized by intraperitoneal injection of
sodium pentobarbital (Nembutal solution, 50 mg/ml, Abbot Laboratories, North Chicago, IL) with
a dosage of 45 mg per kilogram of animal body weight. In some animals an additional injection of
0.05 cc Nembutal solution was necessary to obtain sufficient anesthesia. While unconscious, each
animal's back was shaved and cleaned with Betadine disinfectant scrub (Redi Products, Prichard,
WV). The animal was positioned lying prone on a flat operating board with all four limbs gently
constrained in an extended position by use of rubber bands. The thoracic region of the spine was
slightly elevated by placing a gauze pad under the chest of the animal.
Surgical procedures were performed under aseptic conditions in room 101 of the West
Roxbury Veterans Administration Medical Center animal facility, West Roxbury, MA. A
longitudinal incision, 2 inches long was made through the skin along the animal's back beginning
between the shoulder blades and terminating just below the rib-cage. The underlying musculature
was incised and retracted laterally exposing the dorsal aspect of the bones of the spinal column.
The thoracic 7-9 segments of the spine were identified by measuring the distance away from the
interscapular fat pad and by counting the number of vertebral segments away from the termination
of the rib-cage at thoracic 13. The dorsal half of each vertebral segment (thoracic 7, 8, and 9) was
removed using bone rongeurs and fine surgical scissors. This process, known as a laminectomy,
exposes the spinal cord ensheathed in the dura mater. Minor bleeding was controlled using
Gelfoam (The Upjohn Co., Kalamazoo, MI), and excessive bleeding was stopped using a bipolar
cautery (ValleyLab Inc., Boulder, CO). Local anesthesia was provided as necessary by dripping 1
percent Lidocaine (Abbot Laboratories, North Chicago, IL) into the wound.
The dura mater of segments thoracic 7-9 was incised at the midline using a number 11
blade. Groups of rats were given one of three different surgical lesions as follows (see section
3.1.1 of this thesis for a schematic diagram of each lesion). Hemisection lesions were created at
thoracic 7 by plunging a number 11 blade vertically into the center of the cord and pulling it
laterally away from the center severing half of the spinal cord. Complete transections were
produced by running the blade transversely through the entire spinal cord while maintaining contact
between the tip of the blade and the underlying spinal bones. A 6-mm gap was created by
completely severing the spinal cord at levels of approximately thoracic 7 and 9 and removing
enough intervening tissue to create a 6-mm gap. The cavity was filled with Gelfoam (The Upjohn
Co., Kalamazoo, MI).
Depending on the experimental group to which each animal belonged, the lesion either
remained uncovered or was covered dorsally with a CG dorsal barrier described in the preceding
section. The membrane was placed over the spinal cord in a blanket-like fashion covering the
entire wound bed as shown in Figure 3.4 below.
Figure 3.4. Schematic of CG dorsal barrier covering a 6-mm gap lesion.
The function of the barrier was to isolate the wound site from invasion by scar tissue originating
from muscle tissue, adjacent to the injured cord, which was damaged during the surgical
procedure. Muscle and skin were then closed in layers using 4-0 vicryl sutures (Johnson &
Johnson, Sommerville, NJ) and wound clips.
Animals were housed and cared for post-operatively in room 6 of the West Roxbury
Veterans Administration Hospital animal facility. Unconscious rats were placed on a mild heating
pad for about 6 hours until alert and able to move about the cage. Following injury to the spinal
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cord, animals lost function of their lower limbs but maintained adequate mobility, grooming, and
access to food and water by use of the forelimbs. Animals also temporarily lost reflex bladder
function. For this reason, bladders were voided manually twice daily until reflex function
returned, usually within 2 weeks.
Rats were routinely inspected 4-5 times daily for the first week and twice daily thereafter
for signs of urine scalding and pressure sores. When needed, the skin and fur was washed with
water and Betadine and gently dried. Daily subcutaneous injections of 5 ml lactated Ringer's
solution were given for the first two days to compensate for fluids lost during surgery. Antibiotics
were not administered in this study. Any rats showing continuously poor physical condition were
euthanized by carbon dioxide inhalation.
3.2.4 Animal Sacrifice
At 5 weeks post-operative, rats were deeply anesthetized by intraperitoneal injection of
sodium pentobarbital (Nembutal solution, 50 mg/ml, Abbott Laboratories, North Chicago, IL)
with a dosage of 55 mg per kg of animal body weight. Each rat was positioned with chest exposed
lying on its back in a rectangular Pyrex dish. The forelimbs were gently constrained in an
extended position with surgical tape. The skin and abdominal cavity just below the ribcage were
opened using dissecting scissors. The ribs were cut, and the chest was opened along the sternum
using heavy scissors, exposing the heart. An 18 gauge needle connected to I.V. tubing was
inserted into the left ventricle without entering the right ventricle or exiting the heart chamber. 200
ml of cold heparinized saline (20 units heparin per ml of PBS) was perfused through the left
ventricle with the reservoir of perfusate elevated at a height of 1 meter above the animal.
Heparinized saline was prepared by injecting 20,000 units of heparin (Abbot Laboratories, North
Chicago, IL) into a 1 liter I.V. bag of phosphate buffered saline (PBS). Just as the perfusate
began to flow, the right atrium of the heart was punctured using dissecting scissors allowing body
fluids to exit. The saline solution was immediately followed by 150 ml of Yannofs fixative.
(Detailed Protocols can be found in appendix A).
Following perfusion, the original skin incision was located. The skin and musculature
were reopened using a scalpel. In order to expose a 2-cm segment of the spinal cord, the dorsal
aspect of four additional vertebrae were removed. The exact location of the original spinal cord
lesion was identified. A 15-mm segment of the spinal cord was removed with the lesion site at the
center of the segment. The removed tissue was further fixed in Yannofs fixative for an additional
24 hours at 4oC followed by 10 percent neutral buffered formalin for 24 hours in preparation for
embedding and histological processing.
3.2.5 Histological Processing
Each spinal cord tissue segment was removed from fixative and rinsed thoroughly in PBS.
The tissue was dehydrated by soaking in a series of graded ethanol solutions and prepared for
embedding in paraffin by soaking in two rinses of xylenes (Mallinckrodt Chemical, Paris, KY).
The tissue was infiltrated for 30 minutes in two baths of liquid paraffin (Paraplast+, Oxford
Labware, St. Louis, MO) maintained between 57 and 60'C. The tissue was then oriented for
longitudinal sectioning in a paraffin block and solidified by placing in the refrigerator at 40C for 24
hours. Detailed protocols for paraffin embedding are located in appendix A.
Longitudinal sections were cut at 10-15 ýtm on a microtome (model 1512, Leitz-Wetzlar,
Easton, MA) and floated on water maintained at 46°C in a heated water bath (Lo Boy, Lab-Line
Instruments, Inc., Melrose Park, IL). Tissue sections were captured on glass microscope slides
(Gold Seal Rite-on, Gold Seal Products, Highland Park, IL) and placed in a dehydrating oven
(Harvest Maid, Alternative Pioneering Systems Inc., Chaska, MN) at 45oC for 24 hours to ensure
adhesion of the tissue to the glass slides. Slides were pre-treated with poly-L-lysine solution
(catalog #P8920, Sigma Diagnostics, St. Louis, MO) to enhance tissue adhesion. Sections were
cleared in xylenes and rehydrated through graded ethanol solutions and stained with hematoxylin
and eosin (H&E) or Masson's trichrome. Following staining, slides were dehydrated through
graded ethanol, cleared with xylenes and coverslipped with Permount (Fisher Scientific, Fair
Lawn, NJ). Detailed protocols for histological staining can be found in appendix A.
3.2.6 Data Collection
Post-operative animal survival rate was measured as the fraction of animals in any
particular group which survived the entire predetermined 5-week study period. The number of
days required to regain reflex bladder function was also recorded. An animal was considered to
have regained bladder function when the bladder was found empty before manual voiding for one
or more consecutive days.
Examination of histological tissue sections was performed on a light microscope (Optiphot,
Nikon, Tokyo, Japan), and photomicrographs were generated on 35-mm film with the aid of a
photographic attachment (Microflex AFX-IIA, Nikon, Tokyo, Japan). For each animal, a number
of longitudinal sections were examined to determine the extent of the lesion. This data was
expressed as the percent of the spinal cord cross section area that was severed (% lesion area)
averaged over several histological sections for each animal.
Tissue sections stained with Masson's trichrome were used to assess collagenous scar
tissue formed at the wound site. Tissue from each animal was qualitatively scored on a scale from
0 to 5 based on the amount of fibrous scar tissue found within the lesion. A score of 0
corresponds to minimal scarring, and a score of 5 corresponds to severe scarring. Numerical
scores were used to make qualitative comparisons among groups.
During the surgical procedure, sample implant devices were tested in order to determine if it
is possible to insert a device into each lesion type. After each lesion was created, the surgeon
attempted to insert an implant of the appropriate shape (see section 3.1.2) into the lesion. These
implants were immediately removed and discarded. The purpose of this was not to test the long-
term effects of implantable devices, but only to determine if each lesion type lends itself to the
insertion of an implant device.
3.3 Results
3.3.1 Animal Survival and Bladder Function
Of the 25 animals included in this experiment 13 survived the entire 5-week study period,
which gives an overall survival rate of 52 percent. Table 3.2, below, shows the survival rate of
animals divided by experimental group.
Table 3.2. Survival Rate by Experimental Group
Surgical CG Dorsal Barrier
Lesion A. No B. Yes
I. Hemi-
section
II. Complete 50% 40%
Transection
III. 6-mm 33% 67%
Gap
Animals which survived the surgical procedure regained bladder function between 1 and 20
days post-operative. Over all animals, the average time required was 8.4 days. Table 3.3 below
shows the number of days before return of bladder reflex for animals in each experimental group.
Table 3.3, Number of Days Before
Bladder Function
Return of Reflex
3.3.2 Gross Observations
Upon removal of spinal cord tissue at 5 weeks post-operative, the lesion was grossly
identifiable by the presence of fibrous scar tissue. The lesion site comprised translucent tissue in
contrast to the opaque white appearance of intact healthy spinal cord. In animals which received
complete transection or gap injuries, fibrous tissue was found filling the wound, physically
connecting the rostral and caudal spinal cord stumps. A segment of spinal cord which included the
wound site was easily removed as one continuous piece.
Surgical CG Dorsal Barrier
Lesion A. No B. Yes
I. Hemi- 1.0 days 2.7 days
section
II. Complete 8.7 days 16.0 daysTransection
III. 6-mm 20.0 days 10.5 days
Gap
.
3.3.3 Histological Observations
Measurements of the size of each lesion were made from histological sections. For animals
receiving hemisection lesions, the goal was to reproducibly cut through 50 percent of the spinal
cord cross section. In the 8 animals with hemisection lesions, between 36 and 56 percent of the
tissue was actually severed with an average of 45 percent. For animals receiving a complete
transection lesion, the goal was to completely sever the spinal cord in every animal. Of the 11 I
animals receiving a complete transection lesion, histology confirmed that the spinal cord was
completely severed in only 10 animals. In the one remaining animal, 20 percent of the spinal cord
remained intact. For animals receiving a gap lesion, the spinal cord was completely transected, and
a 6-mm segment of cord was removed, leaving a clear gap. Histological observation confirmed
that the spinal cord was completely severed in all 6 of the animals in this group.
Examination of trichrome stained tissue revealed that fibrous scar tissue was found in the
wound site of all animals. Scar tissue fibers were predominantly oriented in a direction transverse
to the spinal cord axis. A representative lesion site from an animal which received a hemisection
lesion with a CG dorsal barrier (Group IB) is shown in Figure 3.5 below. Fibrous scar tissue (S)
is stained blue, and intact spinal cord is stained red.
Figure 3.5. Fibrous scar filling a spinal cord wound.
As described in section 3.2.6, the tissue of each animal was given a qualitative score
between 0 and 5 based on the amount of fibrous scar found in the wound site. The results of
scoring for fibrous scar for each experimental group are summarized in Table 3.4 below. The
score for each group is the average of all animals in that particular group.
Table 3.4. Scoring for Scar Tissue by Experimental
Group
3.3.4 Device Implantation
As described in section 3.2.6, each lesion type (hemisection, complete transection, and
gap) was evaluated for the feasibility of implanting various experimental devices. For reference,
the diameter of the rat spinal cord is approximately 3 mm. Hemisection and complete transection
procedures generate a very small cavity (less than 0.5 mm wide) between the two cut ends due to
slight retraction of the cord after cutting. The implant devices which fit these cavities (ref. Figure
3.3) are also extremely small (3.0 mm x 0.5 mm). The surgeon found it very difficult to handle
Surgical CG Dorsal Barrier
Lesion A. No B. Yes
I. Hemni- 2.5 1.0section
II. Complete 4.3 2.5
Transection
III. 6-mm 4.0 3.5
Gap
the small implants which fit into hemisection and complete transection lesions. In the surgeon's
opinion, the gap lesion was the most favorable for the implantation of a device. The large 6-mm
gap allowed sufficient space for a much larger implant device (6.0 mm x 3.0 mm) which the
surgeon could easily handle with forceps, insert, and position within the wound.
3.4 Discussion
3.4.1 Animal Survival and Bladder Function
When animals were grouped together by lesion type only (regardless of CG dorsal barrier),
the group receiving hemisection lesions showed a post-operative survival rate of 63 percent,
animals receiving complete transection lesions had a survival rate of 46 percent, and animals
receiving 6-mm gap lesions had a survival rate of 50 percent. This data shows that neither of the
three lesion types resulted in a survival rate substantially different from the overall survival rate of
52 percent.
Data for the number of days required to regain reflex bladder function show that animals in
the hemisection group recovered bladder function in an average of 2.0 days, the complete
transection group in 11.6 days, and the 6-mm gap lesion group in 13.7 days. The difference
between hemisection and complete transection was statistically significant (p=0.001, student's "t"
test), as was the difference between hemisection and gap lesions (p=0.00 3, student's "t" test). The
difference between the complete transection and 6-mm gap groups was not statistically significant
(p-0.6). These data show a trend of increasing time for bladder recovery with increasing severity
of the lesion.
When animals are grouped together depending on the use of the CG dorsal barrier
(regardless of lesion type), animals with a CG dorsal barrier had a slightly higher survival rate (58
percent) than animals without a CG dorsal barrier (46 percent). However, animals with a CG
dorsal barrier recovered reflex bladder function slower (8.7 days) than animals without a CG
dorsal barrier (8.0 days). These differences between groups were not statistically significant.
3.4.2 Lesion Reproducibility
Based on the histological findings, the gap lesion is the most reproducible. The spinal cord
was completely severed in all animals of that group. With a 6-mm gap, it was easy to visually
verify that the spinal cord was completely severed at the time of surgery. The complete transection
lesion was less repeatable, as illustrated by the fact that the spinal cord was not completely severed
in one animal of that group. The surgeon found that it was more difficult to visually verify that the
spinal cord was completely cut when a gap was not created. The hemisection lesion was the least
repeatable. As little as 36 percent or as much as 56 percent of the cord was severed in some
animals. This amount of variation away from the desired 50 percent was deemed to be
unacceptably large.
3.4.3 Device Implantation
The surgeon was not able to effectively implant devices into hemisection or complete
transection lesions due to the small size of the implants (refer to section 3.3.4 and Figure 3.3).
Since the overall goal of this project is to study the use of various devices in the spinal cord, this
finding eliminates hemisection and complete transection lesions as options for this study.
The gap lesion most easily lends itself to the implantation of a device. The large size of the
lesion allows for a larger device which is preferred by the surgeon for handling.
3.4.4 The CG Dorsal Barrier and Fibrous Scar Formation
Hemisection lesions showed the least amount of fibrous scar tissue formed at the wound
site (score of 2.5 without the CG dorsal barrier and 1.0 with it in place). This is expected, since
less damage is initially caused by a hemisection than by a complete transection or a gap. The
scores for scar tissue for the complete transection (4.3 without CG dorsal barrier and 2.5 with it in
place) were similar to the scores for the 6-mm gap group (4.0 without CG dorsal barrier and 3.5
with it in place).
Within each lesion group (hemisection, complete transection, and gap), animals with a CG
dorsal barrier had lower average scores for fibrous scar (see Table 3.4). This confirms the results
of previous studies in which synthetic membranes were used as barriers against the invasion of
fibrous scar into spinal cord wounds36'48 '68,81. Figure 3.6 on the following page shows a complete
transection lesion site which was not covered with a CG dorsal barrier at 5 weeks post-operative.
Figure 3.7 on the following page shows a complete transection which was covered with a CG
dorsal barrier. The wound which was covered with a dorsal barrier contains less fibrous scar
(stained intensely blue by Masson's trichrome).
Figure 3.6. Tissue from an animal receiving a complete transection without CG dorsal
barrier. Stained with Masson's trichrome. A large amount of fibrous scar (S)
has formed in the wound site (outlined by dashes). Scale bar is 1.0 mm.
Figure 3.7. Tissue from an animal receiving a complete transection with a CG dorsal
barrier. Stainedwith Masson's trichrome. Less fibrous scar (S) is found within
the wound site (outlined by dashes). Scale bar is 1.0 mm.
3.5 Conclusions
Based on the results of this study, the 6-mm gap lesion was found to be the most suited to
our purposes. The post-operative animal survival rate (50 percent) was acceptable, and all animals
regained bladder function within a reasonable amount of time (average of 10.5 days). The size of
this lesion was reproducible, and, during the surgical procedure, it was possible to visually verify
that the spinal cord has been completely severed. It was also relatively simple to insert an
experimental implant device into a 6-mm lesion cavity, which was not the case with hemisection
and complete transection lesions.
Use of a CG dorsal barrier limited the invasion of fibrous scar tissue into spinal cord
lesions. As discussed in section 3.1.4, reducing the presence of fibrous scar at the site of the
wound has been associated in the literature with a positive healing response. However, the CG
dorsal barrier was not able to eliminate invasion of fibrous scar.
In conclusion, a 6-mm spinal cord gap with a CG dorsal barrier can provide an animal
model in which the effects of experimental implant devices can be tested.
CHAPTER 4: IMPLANTATION OF TUBULAR DEVICES INTO
THE INJURED ADULT RAT SPINAL CORD
4.1 Introduction
In chapter 3, an animal model of spinal cord injury was established. This model consisted
of a 6-mm gap in the thoracic spinal cord of the adult rat. The goal of the work presented in this
chapter was to use this model to examine the effects of fully resorbable devices on spinal cord
healing. These devices consisted of collagen tubes which either remained empty or were filled
with collagen-glycosaminoglycan (collagen-GAG) matrix. The rationale for using a collagen tube
and the collagen-GAG matrix is discussed in sections 4.1.1 and 4.1.2 below.
4.1.1 Use of Tubes to Repair Peripheral and Central Nervous System Injury
Peripheral Nervous System (PNS)
Tubes were first used to repair the injured peripheral nervous system (PNS) in the late
1800s when Glick used a tube derived from decalcified bone to connect the injured nerve stumps.
Gltick was not successful in restoring function to the denervated region, however, contemporary
investigators have used tubes composed of numerous materials with varying degrees of success.
Other tube materials from animal tissue sources have included arteries"6, veins23, and preformed
mesothelia55. Synthetic tubes have been composed of nylon/millipore6 , silicone78 , and
polysulfone'. Synthetic tubes have the disadvantage that they are not resorbed by the body and
must eventually be removed. Recent studies have investigated the possibility of using degradable
tubes which would be eventually resorbed by the body. Degradable tubes have been formed from
collagen3 '17'49, polyglactin62, polyglycolic acid77, and polylactic acid2 . Tubes implanted at the site
of peripheral nerve injury perform three important functions: 1) isolate the nerve injury site from
invasion by non-nervous tissue originating from sources outside the injured nerve; 2) allow trophic
factors produced by the injured nerve to accumulate; 3) they direct the regrowth of nerve tissue
(including axons) toward the distal stump 56.
Central Nervous System (CNS)
The implantation of tubes into spinal cord lesions has been studied by investigators as early
as 195714. As discussed in the introduction, axons of the central nervous system show little
capacity to spontaneously regenerate, and functional connections are not restored. Investigators
have shown that a limited number of spinal cord axons regrow with the aid of tube implants, but a
return of function has not been demonstrated. Tubes implanted in the spinal cord have been
composed of many substances: nylon/millipore 6,14, PAN-PVC"8 , and polycarbonate63. None of
these tube materials are resorbable within the body. To date, the implantation of resorbable tubes
into spinal cord lesions has not been studied.
We hypothesize that, in a similar fashion to peripheral nerves, entubulating the site of a
spinal cord injury serves three purposes: 1) isolate the wound site from invading non-neural tissue;
2) contain trophic factors produced by the injured spinal cord stumps; and 3) orient the regrowth of
spinal cord tissue to connect the injured stumps. Entubulating the site of spinal cord injury would
also provide an isolated experimental system which consists of the injured spinal cord stumps and
the gap between them.
Figure 4.1. Isolation of spinal cord injury: Experimental system.
Spinal Cord
Experimental System
Spinal Cord
Tube
This closed system can be used to test the effects of exogenous influences which may be
introduced into the tube. In this chapter, two collagen-GAG matrices of different pore structure
were implanted within the tube.
4.1.2 Substrate Preferences of Regrowing Axons
One factor which may contribute to the inability of central nervous system axons to regrow
over significant distances within a lesion may be the absence of an appropriate substrate capable of
supporting the advancement of axon growth cones. Studies in vitro have shown that CNS axons
require a specific environment for regrowth 11'47'60 . Other studies have demonstrated that the
direction of axon outgrowth can be controlled in vitro by providing an aligned substrate material 44.
The regrowth of spinal cord axons along an aligned substrate has also been documented in vivo
45,81
Previous work in this laboratory has shown that injured axons in the peripheral nervous
system (PNS) are able to regenerate across a 15-mm gap in the rat sciatic nerve when the gap is
bridged with a silicone tube containing a collagen-GAG matrix"8 . Axons did not regrow across the
gap when the collagen-GAG matrix substrate was not present within the tube. In a more recent
study, a 10-mm gap in the rat sciatic nerve was bridged with a silicone tube filled with collagen-
GAG matrix with pore channels aligned along the axis of the nerve. The regenerative response
was enhanced by the use of collagen-GAG substrate with aligned pore channels""8 19,'5 . This study
also established that PNS axon regrowth supported by collagen-GAG matrix depends on the pore
structure of the matrix. Collagen-GAG matrix with small pores (5-10 plm average pore diameter)
promotes more efficient regrowth of peripheral nerve axons then collagen-GAG matrix with large
pores (60-300 ýlm average pore diameter)' 9'2 0
The success of tubes filled with collagen-GAG matrix in promoting the regrowth of PNS
axons suggests that a similar implant device may be capable of promoting the regrowth of spinal
cord axons. In this study, collagen tubes containing two collagen-GAG matrices of different pore
size were implanted into spinal cord wounds. Large-pore matrix contains pores with an average
diameter of 95 gm and small-pore matrix contains pores 5 4m in diameter. One purpose of this
study was to determine if collagen-GAG matrix has an effect on early healing response following
spinal cord injury, and if these differences are detectable at the early time point of 30 days.
4.1.3 Fibrous Scarring in Spinal Cord Injury
One factor responsible for the lack of regeneration of axons in the mammalian spinal cord is
the formation of dense fibrous scar tissue in the wound site33' 46,59'64 . The densely packed collagen
fibers of scar tissue have been hypothesized to act as a mechanical barrier to elongating axons46 '7 9
Also, scar tissue may not contain trophic factors which promote axon regrowth or may not provide
vascularity necessary to support growing axons28,30,72 . Axonal regeneration has been reported by
investigators who have used various methods to modify the organization of fibrous scar within
spinal cord wounds'4' 59, 7 9
Figure 4.2. Fibrous scar at the site of spinal cord injury.
Sources of scar tissue in spinal cord wounds include injured muscle tissue, injured bone
tissue, or the meninges (the connective tissue sheath which surrounds the spinal cord) 48'79. In
chapter 3, it was shown that the CG dorsal barrier was effective in reducing fibrous scar ingrowth
from muscle tissue, however, scar was not completely eliminated. The major objective of the
work presented in this chapter was to examine the hypothesis that a collagen tube implant further
isolates the injured spinal cord from intrusion by fibrous scar beyond the protection provided by
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the CG dorsal barrier. A reduction in fibrous scar in the wound site has been hypothesized to lead
to increased regrowth of axons.
4.1.4 Glial Scarring in Spinal Cord Injury
The presence of an intact glial scar at the site of spinal cord injury has also been
hypothesized to inhibit the regrowth of axons31'3 9'60'65. The process of glial scarring consists of the
proliferation of astrocytes, which are support cells in the CNS, and hypertrophy of the astrocyte
processes at the interface between intact neural tissue and damaged or necrotic tissue.
Figure 4.3. Astrocyte (glial) scar at the site of spinal cord injury.
The glial scar serves to encapsulate the intact spinal cord tissue65' 79. The continuous glial scar
which forms surrounding the injured spinal cord stump also prevents axons from regrowing out of
the intact tissue29'43. Previous investigators have hypothesized that spinal cord axons will regrow
if the glial scar does not encapsulate the intact spinal cord. Studies have shown that altering the
formation of a glial scar leads to increased axon regeneration 39. An additional purpose of the study
described in this chapter was to test the hypothesis that tubular collagen-based implants are capable
of inhibiting the formation of the glial scar.
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4.1.5 Objectives of Work in this Chapter
To summarize, the goal of the work presented in this chapter was to compare the effects
various collagen-based devices on early spinal cord healing. Implants consisted of collagen tubes
either empty or filled with collagen-GAG matrix substrate of a well characterized pore structure.
The results were evaluated based on three hypotheses: 1) tube implants prevent the ingrowth of
fibrous scar; 2) tube implants inhibit the formation of the glial scar; and 3) tube implants support
the regrowth of axons.
4.2 Materials and Methods
4.2.1 Animal Model
As described in the previous chapter, an animal model of spinal cord injury was
established. The lesion consisted of a 6-mm gap created in the rat spinal cord at the level of
thoracic 7-9. This lesion can be reproducibly created from one animal to the next and provides a
cavity large enough for the implantation of a device. However, our experience suggested that if the
length of the gap was reduced to 5 mm, a less invasive surgical procedure could be used and
trauma to the animal could be reduced. For the experiments discussed in this chapter, a 5-mm gap
lesion was used.
Also in the previous chapter, it was demonstrated that the CG dorsal barrier was effective
in reducing the amount of fibrous scar tissue invading from injured muscle. For this reason, the
CG dorsal barrier was incorporated into the animal model. For all animals in this study the
wounds were covered with the CG dorsal barrier. All animals were allowed to survive for 30
days.
4.2.2 Experimental Groups
The goal of the work presented in this chapter is to examine the effects of two variables on
the healing of the injured spinal cord: first, the presence of a collagen tube in the wound site, and
second, the presence of collagen-GAG matrix substrate within the tube. In this study, two types
of collagen-GAG matrix were tested: "large-pore" (average pore diameter of approximately 95 pmn)
and "small-pore" (average pore diameter of approximately 5 gm diameter). The combination of
these variables yielded four experimental groups:
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Figure 4.4. Experimental Groups.
The purpose of Group I is to study the intrinsic healing response of the spinal cord without a tube
implanted into the lesion. The purpose of Group II is to study healing when the gap is bridged
with an empty collagen tube. In Groups III and IV, the effect of a collagen-GAG matrix within the
tube was studied. The comparison between Groups III and IV determines if the pore structure of
the collagen-GAG matrix has an effect on the healing response.
4.2.3 Preparation of Implants
Referring to Figure 4.4, implants consisted of a maximum of three components: CG dorsal
barrier, a collagen tube, and collagen-GAG matrix. Group I implants consisted of only the CG
3 mm
-------- M--.%
ddF ------ 0
* ik".2
_,_ __
dorsal barrier covering the wound. For Group II, a collagen tube was implanted in the wound,
and the wound was covered with the CG dorsal barrier. Group m implants included three
components: a collagen tube, which contained large-pore collagen-GAG matrix, and the CG dorsal
barrier. Group IV implants consisted of a collagen tube, which contained small-pore collagen-
GAG matrix, and the CG dorsal barrier. The individual components and the insertion of collagen-
GAG matrix into collagen tubes are described below.
Sterile rectangles of CG dorsal barrier were prepared as described in section 3.2.2. Glass
vials containing sterile CG dorsal barrier were provided to the surgeon at the time of the procedure.
The CG dorsal barrier was used in all animals in this study.
Type I collagen tubes with 3.0 mm ID and 3.1 mm OD were provided in 10-cm lengths by
Integra LifeSciences Corporation (Plainsboro, NJ). The 3.0-mm ID approximately matches the
diameter of the mid-thoracic rat spinal cord allowing for insertion of the spinal cord stumps into the
ends of the tube. These tubes are nominally non-porous but have been shown to allow the passage
of very small molecules such as glucose (180 kDa)5°. The tube walls contain very small pores
(less than 38 A in diameter) which are not permeable to larger proteins or cells. Tubes were
sterilized by dehydrothermal (DHT) treatment at 105'C and a vacuum of 30 mm Hg for 24 hours
before implant assembly discussed below.
Cylinders of collagen-GAG matrix 3.0 mm in diameter were prepared as described in
section 2.2.1. Collagen-GAG matrices of two pore sizes were used in this study: large-pore
matrix (95 plm average pore diameter) and small-pore matrix (5 4im average pore diameter). Both
large and small-pore matrix contain pore channels which are aligned along the axis of the cylinder.
Preparation of implants was performed in a laminar flow hood (Relialab, Tenney
Engineering Inc., Union NJ) using sterile gloves, gown, mask, and instruments. A detailed
protocol for assembly of implants can be found in appendix A. Group I implants consisted of only
the CG dorsal barrier which was described above. Empty tube implants for Group II (see Figure
4.4) were prepared by cutting an 8-mm segment of collagen tube using a scalpel. Segments of
collagen tube, 8 mm in length, were also cut for implants for Group III and IV (see Figure 4.4).
However, these tubes are filled with collagen-GAG matrix; either large-pore for Group III or
small-pore for Group IV. Using forceps, a 5-mm long cylinder of collagen-GAG matrix was
gently inserted into the open end of an 8-mm segment of collagen tube (see figure 4.5).
Figure 4.5. Assembly of tube implants which contain collagen-GAG matrix.
All implants were briefly immersed in sterile 100 percent ethanol followed by two rinses in sterile
phosphate buffered saline (PBS, Sigma, St. Louis, MO). Implants were placed in sterile glass
vials containing sterile PBS. Bottles were transported to surgery in sealed sterile bags (Sterile
Sampling Bags, Fisher Scientific, Pittsburgh, PA).
4.2.4 Surgical Procedure, Device Implantation, and Post-operative Animal Care
The surgical procedure used in this experiment is similar to that described in section 3.2.3.
The animals were adult female Sprague-Dawley rats weighing 250-350 grams (Taconic,
Germantown, NY). Each animal was anesthetized by intraperitoneal injection with sodium
pentobarbital (Nembutal solution, 50 mg/ml, Abbot Laboratories, North Chicago, IL) with a
dosage of 45 mg per kilogram of animal body weight. For some animals an additional injection of
0.05 cc Nembutal was necessary for complete anesthesia. When completely unconscious, animals
were gently restrained in a prone position on a flat operating board. Hair was shaved from the
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back, and the skin was cleaned with Betadine disinfectant scrub (Redi Products, Prichard, WV).
The thoracic region of the spine was elevated by placing a gauze pad under the animal.
Surgical procedures were performed in room 101 of the West Roxbury Veterans
Administration Medical Center animal facility, West Roxbury, MA. A 2-inch long incision was
made through the skin
above the thoracic spine. The underlying musculature was incised along the midline and pulled
laterally using retractors fashioned from paper clips. Muscles attached to the spinous processes
were removed, and the dorsal aspect of thoracic vertebrae 6-10 were identified. A laminectomy
was performed removing the dorsal half of the spinal bones of thoracic 7, 8, and one half of 9.
This procedure exposes about 10 mm of thoracic spinal cord.
A 5-mm gap was created by performing two complete transections at approximately
thoracic 7 and 9. The segment of tissue between the two transections was removed creating a gap
5 mm in length. In animals of Group I (see Figure 4.4 for schematic) the 5-mm gap was created,
and the wound bed was covered with a CG dorsal barrier. In animals of Group II, a 5-mm gap
was produced, and the rostral and spinal cord stumps were delicately inserted into the open ends of
an 8-mm long segment of collagen tube. Saline was injected to fill the tube, and care was taken to
ensure that no air bubbles were present within the tube. With the tube in place, the CG dorsal
barrier was placed dorsally covering the tube as well as both spinal cord stumps. In animals of
Groups III and IV, a 5-mm gap was created, and a collagen tube containing either large-pore
(Group III) or small-pore (Group IV) collagen-GAG matrix was placed between the spinal cord
stumps. Each stump was inserted into the end of the tube abutting the matrix (see Figure 4.4).
Again, the CG dorsal barrier was placed flat over the tube and spinal cord stumps. The opened
muscle and skin were closed separately using 4-0 vicryl sutures (Johnson & Johnson,
Sommerville, NJ) and wound clips. While unconscious, all rats were given a subcutaneous
injection of 100 mg antibiotic (Cefazolin sodium, Abbot Laboratories, North Chicago, IL) diluted
in 0.5 ml distilled water. Antibiotic administration was continued at a dosage of 50 mg per day for
10 days.
Following surgery, animals remained unconscious for 4 to 6 hours. During this time, the
rats were placed on a heating pad to maintain adequately warm body temperature. When the
animals regained consciousness, they were transferred to plastic cages with cellulose bedding
material. Free access to food and water was provided for the duration of the study. Animals
temporarily lost reflex bladder function, and bladders were voided manually twice daily until reflex
function returned. To compensate for blood volume lost during surgery, 5 ml of lactated Ringer's
solution was injected subcutaneously for the first two days following surgery.
4.2.5 Animal Sacrifice
All rats were sacrificed at 30 days after surgery and device implantation. The procedures
described here are similar to those in section 3.2.4 with some slight differences. Each animal was
anesthetized with sodium pentobarbital (Nembutal solution, 50 mg/ml, Abbot Laboratories, North
Chicago, IL) with a dosage of 55 mg per kilogram of animal body weight. The animal was placed
lying on its back in a rectangular pyrex dish with the forelimbs extended and secured using surgical
tape. The chest was opened using heavy scissors exposing the heart. An 18 gauge needle was
used to deliver the perfusate into the left ventricle. The right ventricle was punctured to allow for
the outflow of body fluids. Reservoirs containing cold heparinized saline and cold 4 percent
paraformaldehyde were elevated at a height 1 meter above the level of the animal. Cold heparinized
saline was prepared by adding 20 units of heparin (Abbot Laboratories, North Chicago, IL) for
every one ml of PBS. 4 percent paraformaldehyde was mixed fresh and cooled to 4oC (see
appendix A for a detailed protocol). 200 ml of heparinized saline were perfused followed by 150
ml of 4 percent paraformaldehyde.
4.2.6 Tissue Retrieval and Processing
When each animal was thoroughly perfused, the skin and musculature above the spinal
cord were reopened. The entire thoracic spinal cord (about 20 mm in length) including the lesion
site and implant were removed. The retrieved tissue was cut into 5 segments as schematically
shown in figure 4.6 below.
Figure 4.6. Allocation of retrieved spinal cord tissue.
A 2-mm segment of tissue from the middle of the gap, designated with the label M, was retrieved
and set aside for histological analysis for myelinated axons (see section 4.2.7 below). Tissue
comprising the transition between the intact rostral spinal cord and new tissue which had formed
within the gap was designated R1, and tissue comprising the transition between intact caudal spinal
cord and tissue within the gap was designated Cl. These segments of transition tissue were set
aside for conventional histology and immunohistochemical staining as described in section 4.2.9.
Segments of intact spinal cord tissue farthest away from the gap were cut and stored for future
analysis. These segments were designated R2 and C2.
4.2.7 Tissue Segments from the Middle of the Gap (M)
The 2-mm segment of tissue from the middle of the gap was placed in Yannof' s fixative for
an additional 24 hours followed by 10 percent neutral buffered formalin for 24 hours. To label
myelinated axons, the tissue was post-fixed in 1 percent osmium tetroxide (see appendix A for a
detailed protocol). The tissue was then dehydrated through graded alcohols and embedded in Epon
(PolyBed 812, Ploysciences Inc., Warrington, PA). A detailed protocol for Epon embedding can
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be found in appendix A. Transverse sections were cut at 1 gtm on an ultramicrotome and captured
on glass microscope slides (Gold Seal Rite-On, Gold Seal Products, Highland Park, IL). Sections
were stained with 1 percent toluidine blue solution (Toluidine Blue O, Fisher Biotech, Boston,
MA) and coverslipped with Cytoseal (Stephens Scientific, Riverdale, NJ).
Initial examination of slides was performed with a light microscope (Optiphot, Nikon,
Tokyo, Japan). Myelinated axons were identified by examination with 100X objective lens using
immersion oil. The entire cross section of tissue was examined in an orderly fashion by using an
eyepiece with a transparent grid. For each experimental animal all myelinted axons in the cross
section were counted and recorded. The result was the number of myelinated axons which have
regrown into the middle of the gap at 30 days.
4.2.8 Measurement of Axon Diameters
A quantitative measurement of the diameter of the myelinated axons at the middle of the gap
was obtained via computerized image analysis of the histological images of section 4.2.7 above. A
detailed protocol is located in appendix A. Graphic images (TIFF format) were obtained using a
light microscope (Olympus Vanox-T, Olympus, Japan) equipped with a video camera (Hamamatsu
CCD Video Camera, Hamamatsu, Japan) and video box (Hamamatsu CCD Camera Control,
Hamamatsu, Japan). DIGIT software was used to capture images from the camera.
Computerized stereology software (NIH Image) was used to analyze digitized images.
NIH Image is available on the internet by anonymous ftp from zippy.nimh.gov or on floppy disk
from NTIS, 5285 Port Royal Road, Springfield, VA 22161, part no. PB 93-504868. For each
myelinated axon in an image, the outer surface of the myelin sheath was traced using the mouse,
completely circumscribing the axon. The NIH Image software contains an automated routine
which identifies each axon and measures the length of the perimeter of the axon and the cross
sectional area of the axon. A sample image before and after analysis is shown in figure 4.7 on the
following page. Figure 4.7a shows a digitized image containing numerous myelinated axons.
Figure 4.7b shows the same image after computerized analysis.
Figure 4.7a. Histological image of axons
before analysis.
Figure 4.7b. Image with analyzed axons.
Since axons are not exactly circular in shape, it is not possible to directly measure a true diameter.
The following equation defines an equivalent (hydraulic) diameter for each axon:
4.Aaxon
4axon
where Dh is the equivalent hydraulic diameter of the axon in units of lim, A.on is the measured area
of the axon in ltm 2, and P~on is the measured perimeter of the axon in gtm.
4.2.9 Transition Tissue (R1 and C1)
Following retrieval, tissue segments comprising the transition between intact spinal cord
tissue and new tissue within the gap (R1 and C1 from figure 4.6) were post-fixed in 4 percent
paraformaldehyde for 2-4 hours. The tissue was transferred to a cryoprotective solution of 30
percent sucrose in phosphate buffer for an additional 18-24 hours. Individual tissue segments
were frozen in isopentane (Aldrich Chemical Company Inc., Milwaukee, WI) maintained at -40'C
using dry ice. A detailed protocol can be found in appendix A.
Frozen R1 and C1 segments of tissue were cut longitudinally on a cryostat (Jung Frigolut,
Leica Instruments, Nusseloch, Germany) at 12-20 jim. Sections were captured on pre-treated
glass microscope slides (Superfrost Plus, VWR Scientific, West Chester, PA). Slides were
allowed to air-dry for 45 minutes before conventional or immunohistochemical staining.
Conventional Histology
Slides were rehydrated with two rinses of distilled water and stained with either
hematoxylin and eosin (H&E) or Masson's trichrome. H&E staining was performed to asses
general morphology and to identify cell types present within the tissue. staining with Masson's
trichrome identifies the presence of collagenous tissue. Following staining, tissue sections were
dehydrated through graded ethanol solutions and cleared with two rinses of xylenes. Slides were
coverslipped with Permount (Fisher Scientific, Fair Lawn, NJ). Detailed histological protocols are
located in appendix A.
Immunohistochemistry
Tissue sections adjacent to those used for conventional histology were stained as follows
using immunohistochemical methods. Following air-drying, liquid rubber cement was used to
create a well around each tissue section. The sections are rinsed three times in phosphate buffered
saline (PBS) for 5 minutes each by applying PBS using a pipette. A blocking solution of 10
percent normal goat serum (Gibco Inc., Gaithersburg, MD) was applied for 20 minutes. The
blocking solution was poured from the slides and excess serum was blotted from the section. The
sections were then incubated overnight at 4TC with one of two primary antibodies: anti-glial
fibrillary acidic protein ( aGFAP, Incstar Corp., Stillwater, MN) diluted 1:6 or anti-68 kDa
neurofilament (Oncogene Sciences, Uniondale, NY) diluted 1:400. The GFAP antibody is
polyclonal (made in rabbit) and labels fibrous astrocytes of the glial scar, and the neurofilament
antibody is monoclonal (made in mouse) and labels axons. Following incubation with primary
antibody, the slides are rinsed three times for five minutes each in PBS. The sections are then
incubated for 30 minutes in the appropriate biotinylated secondary antibody solution. Sections
with GFAP primary antibody are incubated in biotinylated goat anti-rabbit IgG (Vector
Laboratories, Burlingame, CA) diluted 1:400, and sections with neurofilament primary antibody
are incubated in biotinylated goat anti-mouse IgG (Pierce, Rockford, IL) diluted 1:400.
Following incubation with the secondary antibody solution, the sections are rinsed three
times for five minutes each in PBS. A solution containing avidin-biotin complex (Vectastain Elite
Kit components, Vector Laboratories, Burlingame, CA) is then applied to the sections for 30
minutes. The sections are again rinsed three times for five minutes each in PBS. The slides are
then developed in a peroxidase substrate solution containing diaminobenzidine (DAB, Sigma, St.
Louis, MO) and hydrogen peroxide. The slides are washed in tap water, dehydrated through
graded ethanol, cleared with two rinses of xylenes, and coverslipped using Permount (Fisher
Scientific, Fair Lawn, NJ). A detailed protocol for immunohistochemical staining is located in
appendix A.
4.3 Results
4.3.1 General Observations
In this study, 24 of 43 operated animals survived to the end of the 30-day period of
investigation. Animals lost function of their hindlimbs following surgery but maintained adequate
mobility, grooming, and access to food and water by use of the forelimbs. Spinal reflexes
remained functional and all animals exhibited a withdrawal reflex in response to cutaneous pinch of
hindlimbs. Reflex bladder voiding function was temporarily lost as a result of spinal cord
transection, and bladders were voided manually until automatic bladder function returned, usually
within two weeks. Recovery of hindlimb motor function was not formally assessed, however no
animals regained the ability to walk or bear weight with the hindlimbs.
4.3.2 Gross Morphology
Gross observation of the excised spinal cord tissue at 30 days revealed that reparative tissue
had formed within the gap between spinal cord stumps in all animals. In animals not receiving a
tube implant (Group I), tissue was found filling the neural canal contiguous with both rostral and
caudal spinal cord stumps. Collagen tubes implanted in animals of Groups II, EI, and IV were
found intact and easily identifiable. The tubes had become integrated with the host spinal cord.
Within implanted tubes, a cable of tissue approximately 1.5 mm in diameter was found connecting
the rostral and caudal spinal cord stumps. Grossly, there was no difference in size and appearance
of the cables of tissue found within tubes which were empty (Group II) or filled with collagen-
GAG matrix (Groups III and IV).
Figures 4.8 and 4.9 are photographs of spinal cord tissue which was retrieved at 30 days
from an animal which received a collagen tube implant which contained small-pore collagen-GAG
matrix (Group IV). In figure 4.8 the collagen tube is intact and identifiable in the wound site. In
figure 4.9, the tube has been removed exposing the cable of reparative tissue.
Figure 4.8. Spinal cord tissue retrieved from an animal which received a collagen tube implant
containing small-pore collagen-GAG matrix. The tube is shown intact integrated
between the spinal cord stumps.
Figure 4.9. The same tissue shown in figure 4.8. The tube has been removed exposing the
cable of reparative tissue within.
4.3.3 General Histological Observations
Examination of histological sections stained with Masson's trichrome revealed that at 30
days, the reparative tissue within the gap contained significant amounts of collagen (stained blue by
trichrome). Staining with hematoxylin and eosin identified the dominant cell types as fibroblast-
like cells and macrophages engulfing debris from necrotic tissue and myelin degradation. The
absence of polymorphonuclear nuetrophils (PMNs), lymphocytes, and granulocytes confirmed that
the implant devices did not elicit prolonged acute inflammatory reaction or foreign body response.
At 30 days, the collagen tube remained intact, but the collagen-GAG matrix was no longer present
within the wound site. This correlates well with previous studies of the peripheral nerve in which
implanted collagen tubes were found intact, but the collagen-GAG matrix had been completely
resorbed by 6 weeks post-implantation 49. It is expected that the collagen tubes will eventually be
resorbed, and other investigators have found that similar collagen tubes were completely degraded
after 3.5 years post-implantation in the monkey median nerve4.
Tissue surrounding implanted tubes was not found to adhere to the tube surface, and tubes
were easily removed intact. Histologically, the tissue adjacent to the tube resembled synovium,
being a definite layer of fibroblasts and macrophages. Tissue found within implanted tubes was
composed of primarily of collagen, and contained fibroblasts, myelinating cells (Schwann cells or
oligodendrocytes), and axons.
4.3.4 Fibrous Scar
Light microscopic examination of tissue sections stained with Masson's trichrome revealed
that reparative tissue found within the 5-mm gap of all groups was composed predominantly of
collagen. Tissue within the injury site of animals not receiving a tube implant (Group I) exhibited
many characteristics of fibrous scar. The collagen fibers within this tissue were densely packed as
identified by intensely blue staining by trichrome. Collagen fibers were observed to be highly
organized and predominantly aligned in a direction perpendicular to the long axis of the spinal
cord. This tissue was also less cellular than tissue found within implanted tubes.
Tissue found within implanted tubes (Groups II, III, and IV) was composed of collagen,
but did not resemble fibrous scar. This tissue was composed of a loosely arranged scaffold of
collagen containing numerous cells resembling fibroblasts and macrophages. This tissue was less
densely organized than fibrous scar. The primary direction of orientation was along the long axis
of the spinal cord.
Figure 4.10 on the following page illustrates the difference between tissue formed in the
absence of a tube and tissue which formed within a tube implant. Both micrographs show tissue
sections taken from the transition between rostral intact spinal cord (stained red by Masson's
trichrome) and newly synthesized tissue within the gap (stained blue by Masson's trichrome). The
tissue section at the top was retrieved from an animal which did not receive a tube implant (Group
I). Collagen fibers within the wound site are densely packed and stain intensely blue. These fibers
are aligned in a direction perpendicular to the long axis of the spinal cord. This tissue resembles
fibrous scar. The tissue section at the bottom was retrieved from an animal which received an
empty tube implant (Group II). The tube has been removed. The reparative tissue is more loosely
organized and aligned in a direction parallel to the long axis of the spinal cord. The loose
arrangement and parallel alignment of reparative tissue was consistent for all animals receiving tube
implants either empty (Group I) or filled with collagen-GAG matrix (Groups III and IV).
Figure 4. 10a. Tissue retrieved from an animal not receiving a tube implant (Group I). Stained
with Masson's trichrome. Dense fibrous scar within the wound stains intensely
blue. Collagen fibers oriented predominantly transerse to the spinal cord axis.
Figure 4.10b. Tissue which had regrown within an empty tube implant. Stained with
Masson's trichrome. Collagenous tissue is loosely organized and stains lightly.
Fibers are oriented predominantly parallel to the spinal cord axis.
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4.3.5 Glial Scar
As described in section 4.2.9, tissue sections were stained with antibodies for GFAP
which positively identify reactive astrocytes, a distinct component of the glial scar. Light
microscopic examination of tissue sections stained with antibodies for GFAP was used to evaluate
the pattern of glial scar formation.
The glial scar which formed at the wound site of animals which did not receive tube
implants (Group I) was consistently found as a continuous barrier between intact spinal cord tissue
and the fibrous scar within the gap. A distinct border of intensely staining GFAP-positive
astrocytes was present in all Group I animals. Reactive astrocytes remained confined to intact
spinal cord tissue and did not grow into the fibrous scar.
Astrocytes had migrated significant distances (greater than 1 mm) into the gap only in
animals receiving tube implants (Groups II, III, and IV). The glial scar was not found to be the
continuous border between intact and reparative tissue, but the border was interrupted by processes
of astrocytes penetrating into the reparative tissue. The interrupted appearance of the glial scar was
common to all animals which received tube implants either empty (Group I) or filled with collagen-
GAG matrix (Groups III and IV).
Figure 4.11 on the following page illustrates the difference in glial scarring
caused by the presence of a tube implant. Tissue sections are adjacent sections to those in figure
4.10 but have been stained with antibodies to GFAP. The tissue section at the top was retrieved
from an animal which did not receive a tube implant (Group I). The fibrous scar within the gap is
unstained and is barely visible (marked by dashed line). GFAP-positive astrocytes form a distinct
border between intact spinal cord and fibrous scar tissue. The tissue section at the bottom was
taken from an animal which was implanted with an empty collagen tube (Group II). Positively
stained astrocytes (arrows) have migrated into the gap. The glial scar is not continuous and
definitely does not form an intact barrier.
Figure 4.1 la. Adjacent tissue section to that of figure 4. 10a (No Tube - Group I). Stained
with GFAP antibodies. Glial scar forms as a distinct border between intact
spinal cord (positive staining) and scar tissue within the gap (unstained as
outlined with dashed line). Astrocytes remain confined to intact spinal cord.
Figure 4.1 lb. Adjacent tissue section to that of figure 4.10b (Empty Tube - Group II). Stained
with GFAP antibodies. Glial scar is disrupted by positively staining astroytes
(arrows) extending into the tissue cable. Astrocytes have migrated into the
tissue cable.
4.3.6 Myelinated Axons at the Middle of the Gap
Transverse sections of Epon embedded tissue from the midpoint of the gap revealed that the
reparative tissue of all animals was well-vasularized, containing numerous blood vessels and
vascular channels. This tissue also contained myelinated axons in 20 of 24 animals including
animals of all experimental groups. Axons were typically organized into small bundles or
fascicles closely associated with myelinating cells which appeared to be Schwann cells. Figure
4.12 below is a micrograph of mature myelinated axons (arrows) in a normal rat spinal cord.
Myelin is stained darkly blue by toluidine blue. Figure 4.13 is a micrograph of tissue from an
animal which received a collagen tube containing large-pore collagen-GAG matrix. Numerous
myelinated axons have regrown at 30 days (arrows).
Figure 4. 12. Mature myelinated axons (arrows) in a normal adult rat spinal cord.
Figure 4.13. Myelinated axons (arrows) which have regrown at JU clays into a collagen
tube which contained large-pore collagen-GAG matrix.
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The chart in figure 4.14 shows the total number of axons counted at the middle of the gap
for each of the four experimental groups. Each value is shown as the average for animals in each
group with error bars expressing standard error of the mean (SEM). The number of animals in
each group is also shown.
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Figure 4.14. Results of axons counting for the four experimental groups.
Animals of Group I showed the largest number of myelinated axons at the center of the wound
with 658 ± 238 (mean ± SEM, n=5) myelinated axons. The average number of axons for Group
II was 594 ± 289 (n=5). Animals of Group III showed the smallest number of regrowing axons
with 272 ± 186 (n=5), and Group IV animals showed 587 ± 258 (n=9) myelinated axons.
For each group, the individual data points were not normally distributed about the mean.
This fact invalidates the use of a standard ANOVA or student's t-test for statistical comparisons
among groups. The Mann-Whitney non-parametric test does not assume normal distribution and
was applied to the data for statistical comparisons 70. Using the Mann-Whitney test, theere were no
statistical differences (p>0.05 for all comparisons) between groups for the number of myelinated
axons found in the wound at 30 days.
As described in section 4.2.8, the diameters of axons found in the wound site were
measured. Myelinated axons ranging between 1 and 9 gtm were identified. The data was compiled
as a histogram showing the size distribution of regenerated axons for each experimental group.
Figures 4.15 through 4.18 on the following pages show the diameter distribution for myelinated
axons in each of the four experimental groups. Axons 3-4 ýtm in diameter were most numerous
with fewer small diameter (<3 .tm) and large diameter (>4 itm) axons. The diameter distributions
were qualitatively similar among groups.
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Figure 4.15. Histogram showing the axon diameter distribution for all animals of
Group I (No Tube). Axon diameters divided into bins from 1 to 9 jim.
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Figure 4.16. Histogram showing the axon diameter distribution for all animals of Group
II (Empty Tube). Axon diameters divided into bins from 1 to 9 gnm.
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Figure 4.17. Histogram showing the axon diameter distribution for all animals of Group III
(Large-Pore Matrix). Axon diameters divided into bins from 1 to 9 ptm.
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Figure 4.18. Histogram showing the axon diameter distribution for all animals
(Small-Pore Matrix). Axon diameters divided into bins from 1 to
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4.4 Discussion
The goal of this study was to evaluate the effects of various collagen-based implant devices
on spinal cord healing. The devices consisted of a collagen tube which was either empty or filled
with large-pore or small-pore collagen-GAG matrix. The effects of the presence or absence of the
collagen tube and the presence or absence of collagen-GAG matrix are discussed below. The
differences in healing response among implant groups is discussed in terms of the endpoints of
fibrous scar, glial scar, and the regrowth of axons.
4.4.1 Effects of Collagen Tube Implants on Spinal Cord Healing
General examination of excised tissue and histological observation revealed that collagen
tubes did not elicit an untoward inflammatory response or a foreign body reaction. At 30 days,
tubes had become integrated with the host spinal cord tissue, and tissue formed within the tube
contiguous with the rostral and caudal spinal cord stumps. These findings are similar to previous
observations from this laboratory in work with peripheral nerves1 720' 4 9' 53'88
As expressed in section 4.3.4, fibrous scar had formed in the wound site of animals when
collagen tubes were absent (Group I). Fibrous scar was not present in the wound site of animals
receiving collagen tube implants either empty (Group II) or filled with collagen-GAG matrix
(Groups III and IV). We hypothesize that the collagen tube excluded the invasion of fibrous scar
from external connective tissue sources. The tissue within the tube contained collagen but lacked
the dense organization characteristic of fibrous scar. The alignment of collagenous tissue within
implanted tubes suggest that the tubes provide guidance for the regrowth of tissue between the
injured stumps. Although it was not formally addressed by this study, aligned collagen fibers
within implanted tubes may provide for the directed regrowth of axons.
The presence of collagen tubes also altered the pattern of glial scar formation (see section
4.3.5). In the absence of implanted tubes (Group I), astrocytes remained confined to the intact
spinal cord tissue and did not migrate into the wound site. The glial scar also formed a distinct
continuous border between intact spinal cord tissue and fibrous scar within the gap. When
collagen tubes were implanted (Groups II, Im, and IV) astrocytes were able to migrate significant
distances (> 1 mm) into the gap. Also, the glial scar was visibly disrupted at the interface between
intact spinal cord and reparative tissue. We hypothesize that the tube provides guidance for the
regrowth of tissue from spinal cord sources within the gap. This tissue includes astrocytes and
myelinating cells. Myelinating cells were identified at the middle of the gap in Epon embedded
sections stained with toluidine blue. The growth of tissue of spinal cord origin into the wound site
is encouraging.
Animals receiving tube implants did not show a significantly larger number of axons at the
middle of the wound site at 30 days than animals without tube implants (see section 4.3.6). At the
relatively early time point of 30 days, the scatter in the data is somewhat large. Changes caused by
the implantation of a tube may not be evident at 30 days, and a longer interval of evaluation may be
necessary.
Tube implants also provided an isolated experimental system for the study of spinal cord
healing. At 30 days, both spinal cord stumps were found in place within the tube in all
experimental animals. This experimental system introduces the possibility of testing the effects of
other therapeutic elements which could be delivered within the tube.
4.4.2 Effects of Collagen-GAG Matrix on Spinal Cord Healing
The presence or absence of the collagen-GAG matrix within implanted tubes did not have
as striking effect on the healing response as the presence or absence of the tube itself. The
formation of fibrous scar within the wound was not noticeably different when collagen-GAG
matrix of either pore size was present. Also, the pattern of glial scarring which formed in animals
receiving implants containing collagen-GAG matrix was not different from animals with empty
tubes. The pore geometry of the matrix did not effect fibrous or glial scar formation.
There were no statistically significant differences (p>0.05 for all comparisons) in the
number of axons which had regrown into empty tubes (Group I) or those containing large-pore
matrix (Group III) or small-pore matrix (Group IV). It appears that at the early time point of 30
days, no conclusions can be reached about the effects of collagen-GAG matrix on the spinal cord
healing response. Perhaps a longer evaluation period is necessary to detect differences between
implant groups.
4.4.3 General Remarks
The overall goal of research in spinal cord healing and regeneration is to re-establish
functional connection through a lesion site. The first step in this process is to encourage damaged
axons to regrow through a lesion site. Our results demonstrate that a number of axons are able to
regrow into the lesion. At 30 days, there were no statistically significant differences in the number
of axons among groups. A longer period of observation may yield more information about the
effects of implant devices on healing and axon regeneration.
Axons which have regrown into a spinal cord wound can originate in three possible
sources. The regrowing axon may belong to a neuron cell body located in the brain or brainstem,
in the spinal cord itself, or in the peripheral nerve roots. When evaluating the regeneration of
spinal cord axons, it is important to identify the source of regrowing axons since axons from
different sources correspond to the return of different types of function. Future studies will
determine the origin of the regrowing axons.
4.5 Conclusions
In this experiment, the healing response within the closed environment within implanted
tubes was characterized. An experimental system for the study of spinal cord injury has been
established. We have also shown that with the implantation of collagen-based devices, we are
capable of controlling aspects of the healing response which may affect successful regeneration.
The presence of collagen tubes reduces the ingrowth of fibrous scar which has been shown to
inhibit successful regeneration. Also, the tube provided guidance for the regrowth of tissue from
neural sources into the wound site. The experimental system also provides an opportunity for
future research in which various therapeutic elements (pharmaceutical agents, growth factors,
cultured cells, etc.) may be delivered to the injury site and tested.
The presence of myelinated axons within the wound site is encouraging. The regeneration
of axons is the first step toward the recovery of function. We have also established an
experimental system that will allow for the testing and identification of other factors which may
encourage a more robust regrowth of axons. Future work in this lab will also be focused on
guiding these axons toward their original endpoints.
Fully resorbable collagen-based devices show promise in facilitating regenerative changes
following profound injury in the central nervous system.
APPENDIX Al: COLLAGEN SLURRY PROTOCOL
PROCEDURE:
1. Defrost wet (Integra) tendon collagen. 30 min. - 1 hr.
2. Also, cool blenders for 30 min to 40 C.
3. Fill one blender with 600 ml of 0.05M acetic acid
4. Weigh 13.69g of wet tendon collagen. The collagen is in pre-packaged bags, but still
needs to be weighed.
5. Pull the collagen into small bits using forceps and drop collagen in blender.
6. Blend for 90 min. on high.
7. Add 120 ml of chondroitin 6-sulfate solution over 15 min using the peristaltic pump.
(0.32g C-6-S in 120 ml 0.05M acetic acid.)
8. After the addition, blend the mixture for an additional 90 min. on high.
9. Pour out slurry and refrigerate.
10. If using immediately, de-gas slurry with a vacuum flask in the hood. It is now ready
to pour into the freeze-drying tray.
APPENDIX A2: PREPARATION OF COLLAGEN-GAG
MATRIX
PROCEDURE:
1. Connect the freezing bath hose to the "liquid" port on the liquid nitrogen tank. Open the
valve on the tank by turning counter-clockwise. Press the switch turning the freezing bath
power on. The liquid nitrogen should start flowing immediately. Set the desired
temperature on the controller dial. The temperatures marked may not be accurate, you may
need to make adjustments. The freezing bath should cool in about 30 minutes, depending
on the desired temperature.
2. Turn on the Vitrtis freezedryer. Power: ON, Freeze: ON, Heat: ON, Condenser: ON,.
Set the temperature (SV) to -200 C. Turn on the ventilation fan located behind the
freezedryer. Place the implant tray in the freezedryer to cool. It will take about 30 minutes
to cool down.
3. Prepare each implant for freezing as follows. Cut 10 cm of PVC Tygon jacket tubing
(1/4" ID, 3/8" OD). Cut 15 cm of silicone tubing (5/32" ID, 7/32" OD, Cole Parmer
#06411-65). Clamp one end of the silicone tube with a non-hanging clamp. Thread the
unclamped end into the section of PVC jacket tubing until the PVC abuts the clamp. Open
the clamp slightly. Remove the slurry from the refrigerator (if the slurry has been sitting
for more than one week re-blending may be necessary). Using a syringe without a needle,
carefully draw slurry without air bubbles. Inject slurry into the free end of the silicone tube
until the slurry completely fills the tube. Inspect the tube for air bubbles in the slurry.
Close the clamp securely and remove the syringe. Push the free end of the silicone tube
into a hanging clamp until the PVC tubing abuts the clamp. Close this clamp securely.
The implant is now ready to be frozen.
4. Check the temperature of the freezing bath. Check the size of the gear on the lowering
motor. Hang the implant from the lowering track. Align the implant so that it will not
stick to the freezing coils or the sides of the bath. Turn on the lowing motor and wait for
the implant and clamps to become completely submersed in the coolant (20 minutes - 2
hours for different speeds). Wait 30 minutes for complete freezing. While the implant is
lowering prepare labels for the individual specimen sections.
5. Before removing the implant from the bath, retrieve the cold tray from the freeze dryer.
Remove the implant from the bath. Remove the clamps. Cut away the excess silicone
tubing outside of the PVC keeping track of which end of the tube had entered the bath first
Cut the PVC and silicone into 2.5 cm sections. Label each section accordingly (1-4 with
section 1 entering the bath first). Place these sections quickly onto the cold tray.
6. Place the tray in the freeze dryer and close the door securely. Check the condenser
temperature to make sure it is below -40o C. Make sure the chamber release button if OFF.
Turn the vacuum ON. Make sure the front door seals. Once the vacuum is below
200 mtorr (about 30 minutes) change the temperature setting to 00 C. Leave both the freeze
and heat buttons ON. Leave at 00 C overnight.
7. The next day change the temperature setting to 200C and turn OFF the freeze button
(leave the heat button ON). While the temperature is rising (about 20 minutes), prepare
individual foil packets for implants labeled with specimen number, date, and sterile
condition. When the temperature reaches 200 C turn the heat, vacuum, and condenser
buttons OFF. Turn the chamber release button to ON. When the vacuum is fully released,
remove the implants into the foil packets leaving the top edge wide open.
8. Place the foil packets containing the implants in the DHT oven at 105 C overnight with
the vacuum on. In the morning, release the vacuum and carefully close the tops of the
packets trying to maintain the sterile condition. Place the packets in the desiccating boxes
for storage.
APPENDIX A3: IMPLANT ASSEMBLY
Sterilized Equipment:
Forceps (2 pair)
Small scissors
3 small specimen vials
Scalpel holder
Teflon pad enclosed in packet
Ruler
2 small glass culture dishes for PBS and EtOH
Other Equipment (pre-sterilized -just open and drop into or near sterile field):
#10 scalpel blade
Sterile collagen tubes
Sterile matrix
Sterile collagen membranes
3 sterile disposable transfer pipettes
Sterile 100% EtOH
Sterile PBS
Whirl-Pak
PROCEDURE:
Day before implant preparation (at least 3 hours before):
1. Enclose instruments in autoclave bag and seal with autoclave tape.
2. Enclose teflon pad in wrap and seal with autoclave tape.
3. Place both in autclave upright leaning against walls.
4. Replace Plug and fill autoclave with water. Turn timer to 45 mintues on FAST exhaust
setting.
5. Allow instruments to cool before removing.
Day of implant preparation:
1. Turn on the sterile hood blower at least 1 hour before working.
2. Spray entire bench surface with 70% EtOH and wipe with Kimwipe.
3. Open EtOH and PBS bottles and Whirl-Pak.
4. Open packet containing teflon pad to create sterile field.
5. Drop equipment into sterile field.
6. Put on sterile gloves
7. Using forceps gently push matrix segments into collagen tubes.
8. Dropwise flow sterile 70% EtOH through matrix within tube for 1 mintue.
9. Dropwise flow sterile PBS for 1 mintue.
10. Place implant and one piece of collagen membrane in vial filled with PBS and close lid.
11. Place vials in Whirl-E-Packs and close
APPENDIX A4: PREPARATION OF CG DORSAL BARRIER
PROCEDURE:
1. Pour degassed collagen-GAG slurry into an aluminum weigh boat to
depth of about 3/8" (3.5 ml per square cm of drying pan area).
2. Place in the Fisher vacuum oven at room temperature and 25-30 mm Hg
vacuum until no more bubbles form (about 30 minutes).
3. Remove from oven and place under the laminar flow bench or sterile
hood at room temperature for 3 to 4 days until dry.
4. Prepare foil packets large enough to hold three implantable pieces
of collagen-GAG membrane. Remove the membrane from the weigh boat
using jeweler's forceps. The membrane should be removed in one piece.
5. Measure the thickness of the membrane using micrometer in a number
of locations and record the result. The thickness should be within
the range 0.004 and 0.006 inches.
6. Cut the membrane into rectangular pieces 8 mm by 12 mm. Place
three of these pieces in each foil packet leaving the end wide open.
7. Place the packets into the Fisher oven at 105 degrees Celsius and
25-30 mm Hg vacuum for 24 hours.
8. The next day remove the packets, seal the opening by folding twice
and place in the desiccating box for storage.
APPENDIX A5: ANIMAL SACRIFICE BY CARDIAC
PERFUSION
EQUIPMENT:
IV bottle with 2-hole plug and breather tube 18 gage needle
IV tubing (2 sets) dissection instruments
3-way stopcock specimen jars
Pyrex dish Nembutal solution
1 liter IV bag of PBS tuberculin syringes/needles
SOULUTIONS:
Heparinized Saline (20 units/ml)
1 liter IV bag of PBS
2 ml of heparin sodium (10,000 units/ml)
Measure heparin by drawing into tuberculin syringe and inject into IV bag. Mix
and keep cold (40C) until use.
Yannof's Fixative
Stock A: 1.67g Sodium Phosphate (monobasic, anhydrous)
8.95g Sodium Phosphate (dibasic, anhydrous)
960 ml distilled water
40 ml 25 percent glutaraldehyde
Stock B: 4.0g Sodium Phosphate (monobasic, anhydrous)
8.95g Sodium Phosphate (dibasic, anhydrous)
900 ml distilled water
100 ml 38-40 percent formaldehyde
Mix equal parts of stock A and B. Keep refrigerated (4QC) until use.
4 % Paraformaldehyde (100 ml, pH 7.4)
4.0g paraformaldehyde powder
50 ml distilled water
IN Sodium Hydroxide Solution
50 ml 0.2 M phosphate buffer
Add 4.0g paraformaldehyde to 50 ml distilled water; heat to 600C. Add a few
drops of sodium hydroxide until the solution clears slightly. Cool to room
temperature. Add 50 ml of 0.2 M phosphate buffer. Filter and pH to 7.4. Mix
fresh for each group of animals and keep cold (40C) until use.
SOULUTIONS (CONTINUED):
0.2 M Phosphate Buffer (500 ml, pH 7.4)
500 ml distilled water
3.0g Sodium Phosphate (monobasic, anhydrous)
11.0g Sodium Phosphate (dibasic, anhydrous)
Mix constituents and pH to 7.4.
PROCEDURE: (note the procedure is the same for perfusion with Yannof s or 4 %
paraformaldehyde)
1. Prepare necessary solutions and cool to 4oC.
2. Inject animal IP with pentobarbital with dosage of 55 mg per kg of animal body weight.
3. Hang IV bottle of cold perfusate and IV bag of cold saline 1 m above the level of the
animal using harness or IV stand. Connect the IV tubing with 3-way stopcock connected
to perfusate, saline, and 18 gage needle.
4. Place unconscious animal lying on its back in the pyrex dish with arms constrained
slightly extended using tape.
5. Using heavy dissecting scissors, open the chest, exposing the heart. Partially open the
stopcock to allow some saline through the needle. Insert the needle into the left ventricle of
the heart without puncturing the opposite side of the heart. Open the flow of saline and cut
the right atrium to allow for outflow of body fluids. Allow 200 ml of heparinized saline to
flow.
6. Change the stopcock to allow for the flow of perfusate (either Yannof's fixative or 4 %
paraformaldehyde). Allow 150 ml of perfusate to flow.
APPENDIX A6: PARAFFIN EMBEDDING PROTOCOL
EQUIPMENT:
Hot plate
square metal baking pan
2 wide-mouth bottles for paraffin
thermometer (range 0-100oC)
long forceps
Tissue-tek cartridges
paraffin molds
Blue-ice block
Papaplast+
PROCEDURE:
1. Fill the square metal baking pan with water and place on hot plate (setting of around 4 on
our hot plates). Also nearly fill two wide-mouth bottles with paraffin chips and place them
in the water on the hot plate.
2. While the paraffin is melting dehydrate the tissue pieces through graded alcohols as
designated below. Also thoroughly clear with two xylene rinses.
3. Once the paraffin has reached 580C and the tissue is dehydrated and cleared, place each
tissue piece into a Tissue-tek cassette for handling. Be careful not to heat the paraffin
above 60oC. Infiltrate the tissue within the cassettes for 30 minutes each in two baths of
paraffin.
4. When the tissue has been infiltrated, remove it from the cassette and place into a paraffin
mold with melted paraffin. Position the tissue in the desired orientation and immerse the
"chuck" half of the cassette into the paraffin above the tissue. Place the paraffin mold on
the ice block to solidify the paraffin. Using a pencil, label the sample on the surface of the
"chuck" half of the cassette.
1. 70% EtOH 5 minutes Room Temp
2. 70% EtOH 5 minutes Room Temp
3. 80% EtOH 5 minutes Room Temp
4. 95% EtOH 5 minutes Room Temp
5. 95% EtOH 5 minutes Room Temp
6. 100% EtOH 5 minutes Room Temp
7. 100% EtOH 5 minutes Room Temp
8. 100% EtOH 5 minutes Room Temp
9. Xylenes 5-10 minutes Room Temp
10. Xylenes 5-10 minutes Room Temp
11. Paraffin 30-45 minutes 580C
12. Paraffin 30-45 minutes 580C
APPENDIX A7: EPON EMBEDDING PROTOCOL
SOLUTIONS:
Cacodylate Buffer (pH 7.4)
Stock A: 0.2 M sodium cacodylate (mw 214)
4.28g sodium cacodylate in 100 ml of distilled water
Stock B: 0.2 M HCl (mw 36.46)
1.7 ml HCI in 100 ml of distilled water
Mix 25 ml of stock A + 1.4 ml of stock B (for pH 7.4) +73.6 ml of distilled
water.
2 % Cacodylate Buffered Glutaraldehyde
8 ml of 25% glutaraldehyde
92 ml cacodylate buffer
0.2 M Cacodylate Buffered Sucrose Solution
6.846g sucrose (mw 342.3)
100 ml cacodylate buffer
1% Osmium Tetroxide
2 ml 4% osmium tetroxide solution
6 ml distilled water
PROCEDURE:
1. Soak tissue pieces in 2% cacodylate buffered glutaraldehyde overnight at 4oC.
2. Soak tissue pieces in 0.2 M cacodylate buffered sucrose overnight at 4°C.
3. Rinse tissue one time in cacodylate buffer for 10 minutes at 4oC.
4. Fix in 1% osmium tetroxide for 1.5 - 2.0 hours at room temperature (in the hood).
5. Dehydrate tissue through graded alcohol:
30% EtOH 5 minutes
50% EtOH 5 minutes
70% EtOH 5 minutes
80% EtOH 5 minutes
90% EtOH 5 minutes
95% EtOH 5 minutes
100% EtOH 5 minutes
100% EtOH 5 minutes
100% EtOH 5 minutes
100
6. Clear in acetone with 2 rinses for 5 minutes each.
7. Infiltrate in 1:1 acetone/Epon* mixture overnight at room temperature.
8. Infiltrate in 1:3 acetone/Epon* mixture overnight at room temperature.
9. Infiltrate in 100% Epon* overnight at room temperature.
10. Embed with 100% Epon with hardener using flexible molds. A small piece of paper
containing identification for each specimen can be solidified into the Epon block.
11. Let cure for 24 hours in the oven at 60oC. Some samples may take longer to harden.
*During infiltration, the Epon mixture should not contain hardener.
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APPENDIX A8: TISSUE FREEZING
EQUIPMENT:
Low temperature thermometer (-100oC to OoC)
Ring stand with clamp
Small metal vessel (-50 ml volume)
Larger metal bowl (-500 ml volume)
Isopentane
Dry Ice
Forceps
Tissue-tek OCT embedding compound
Strips of filter paper
PROCEDURE:
1. Place enough dry ice pieces in the bottom of the 500 ml bowl to cover the bottom.
2. Place the 50 ml vessel in the center of the dry ice in the bowl.
3. Clamp the thermometer in the ring stand so that the tip is placed within the 50 ml vessel.
4. Fill the 50 ml vessel with isopentane. Adjust the amount of dry ice in the bowl until the
temperature equilibrates to -400C. The dry ice will need to be replenished to maintain the
temperature.
5. Label a strip of filter paper corresponding to a tissue segment. Place a drop of OCT
compound on the end of the paper, and place the tissue on the drop of OCT in the correct
orientation.
6. Immerse the tissue in the isopentane by dipping the end of the paper strip into the
isopentane for about 10 seconds (larger tissue pieces will take longer). Immediately place
the frozen tissue into the freezer at -80'C.
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APPENDIX A9: HEMATOXYLIN AND EOSIN STAINING
SOLUTIONS:
Harris Hematoxylin Solution
(Sigma Co, )
HC1, conc.
70% EtOH
ammonium hydroxide
Distilled water
Eosin
(Sigma
.25% Acid Alcohol Solution
2.5 ml
1000.0 ml
Ammonia Water Solution
5-6 drops
200.0 ml
Y Solution, Aqueous
Co., Cat No. HT110-2-16)
STAINING PROCEDURE:
1. Deparaffinize and hydrate to distilled water.
xylene
100% EtOH
95% EtOH
80% EtOH
70% EtOH
tap water
2 minutes 2X
1 minute 2X
1 minute
1 minute
1 minute
10 minutes
2. Stain with Harris Hematoxylin for 2-3 minutes.
3. Rinse with distilled water.
4. Differentiate with acid alcohol solution for 1-2 dips.
5. Rinse with distilled water for 5- 10 seconds.
6. Dip in ammonium hydroxide solution 5-60 seconds
7. Rinse with distilled water for 2 minutes.
8. Dip in eosin for 3 seconds.
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9. Dehydrate and clear.
70% EtOH
80% EtOH
95% EtOH
100% EtOH
xylene
minute
minute
minute
1 minute 2X
2 minutes 2X
10. Mount with Permount or Histoclad.
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APPENDIX A10: MASSON'S TRICHROME STAINING
(Manual of Histological Staining: Methods of the Armed Forces Institute of Pathology,
III Ed, 1968, pp.94-95)
SOLUTIONS:
Bouin's Solution
(Sigma Co.)
Weigert's Iron Hematoxylin Solution
Solution A:
Hematoxylin crystal 1.0 gm
Alcohol, 95% 100.0 ml
Solution B:
Ferric Chloride, 29% aqueous4.0 ml
distilled water 95.0 ml
HC1, conc 1.0 ml
Mix equal part of solution A and solution B.
Biebrich Scarlet-Acid Fuchsin Solution
Biebrich scarlet, aqueous, 1% 90.0 ml
Acid fuchsin, aqueous, 1% 10.0 ml
Glacial acetic acid 1.0 ml
Phosphomolybdic-Phosphotungstic
Phosphomolybdic acid 5.0 gm
Phosphotungstic acid 5.0 gm
Distilled water 200.0 ml
Aniline blue
Glacial acetic acid
Distilled water
Glacial acetic acid
Distilled water
Aniline Blue Solution
2.5 gm
2.0 ml
100.0 ml
1% Glacial Acetic Acid Solution
1.0 ml
100.0 ml
STAINING PROCEDURE:
1. Deparaffinize and hydrate to distilled water.
xylene 2 minutes 2X
100% EtOH 1 minute 2X
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Acid Solution
95% EtOH 1 minute
80% EtOH 1 minute
70% EtOH 1 minute
tap water 10 minutes
2. Mordant in Bouin's solution for 1 hour at 56°C, or overnight at room
temperature, if formalin fixed.
3. Cool and wash in running water until yellow color disappears.
4. Rinse in distilled water.
5. Weigert's iron hematoxylin solution for 10 minutes. Wash in running water 10
minutes.
6. Rinse in distilled water.
7. Biebrich scarlet-acid fuchsin solution for 2 minutes. Save solution.
8. Rinse in distilled water.
9. Phosphomolybdic-phosphotungtic acid for 10 to 15 minutes before aniline blue
solution. Discard solution.
10. Aniline blue solution for 5 minutes. Save solution.
11. Rinse in distilled water.
12. Glacial acetic solution for 3 to 5 minutes. Discard solution.
13. Dehydrate and clear.
70% EtOH 1 minute
80% EtOH 1 minute
95% EtOH 1 minute
100% EtOH 1 minute 2X
xylene 2 minutes 2X
14. Mount with Permount or Histoclad.
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APPENDIX All: TOLUIDINE BLUE STAINING
SOLUTIONS:
Toluidine Blue Solution
Toluidine Blue Powder 1 gm
Sodium Borate Powder 1 gm
Distilled Water 100 ml
Solution should be filtered and stored in a stopped bottle.
STAINING PROCEDURE:
1. Heat slide on hot plate to 60 - 800C.
2. Stain with Toluidine Blue Solution for 30 - 60 seconds. Thicker sections will
take less time.
3. Wipe away excess stain and allow to dry on hot plate for 2 - 3 minutes.
4. Mount with Permount or Histoclad.
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APPENDIX A12: IMMUNOHISTOCHEMICAL STAINING
SOLUTIONS:
0.2 M Phosphate Buffer (500 ml, pH 7.4)
500 ml distilled water
3.0g Sodium Phosphate (monobasic, anhydrous)
11.0g Sodium Phosphate (dibasic, anhydrous)
Mix constituents and pH to 7.4.
Primary Antibody Dilutant
10ml 5ml 2.5 ml
PBS 9.488 ml 4.744 ml 2.372 ml
10% Triton X-100 0.300 ml 0.150 ml 0.075 ml
Goat Serum* 0.200 ml 0.100 ml 0.050 ml
(*species is chosen based on the species of the secondary antibody)
Secondary Antibody Dilutant
10 ml 5 ml 2.5 ml
PBS 9.500 ml 4.750 ml 2.375 ml
Normal Goat Serum 0.150 ml 0.075 ml 0.0375 ml
10% Triton X-100 0.300 ml 0.150 ml 0.075 ml
10% Normal Goat Serum (First Block)
10 ml 5 ml 2.5 ml
PBS 8.700 ml 4.350 ml 2.175 ml
Goat Serum 1.000 ml 0.500 ml 0.250 ml
10% Triton X-100 0.300 ml 0.150 ml 0.075 ml
DAB Substrate Solution
Tris (room temp) 25 ml
Diaminobenzidine (Sigma) 12.5 mg
Just before use add:
Hydrogen Peroxide (30%) 8.3 pl
Phosphate Buffered Saline (PBS)
Distilled Water 1000 ml
Sodium Phosphate (monobasic, anhydrous) 3.0 g
Sodium Phosphate (dibasic, anhydrous) 11.0 g
Sodium Chloride 8.5 g
pH to 7.4
108
SOLUTIONS (CONTINUED):
Avidin-Biotin Complex (ABC) Solution
PBS 4.85 ml
10% Triton X-100 0.075 ml
Solution A (Vector Kit) 0.025 ml
Shaken then add:
Solution B (Vector Kit) 0.025 ml
Mix approximately 30 minutes before use
Tris Buffer
Distilled water 1000 ml
Trizma Base 6.0 g
STAINING PROCEDURES (for frozen cut sections):
1. Air dry slides 30 minutes to one hour. Make wells around tissue sections while the
slides are drying using a syringe.
2. PBS rinse three times for 5 minutes each. Keep slides in a humidified chamber (we use
a slide box with wet paper towels in the bottom.
3. Incubate in 10% Normal Goat Serum for 20 minutes.
4. Apply the primary antibody (whichever antibody is appropriate) diluted to desired
concentration with primary antibody dilutant. Incubate overnight in a coldroom at 40C.
5. PBS rinse three times for 5 minutes each.
6. Apply the appropriate secondary antibody diluted with secondary antibody dilutant.
Incubate for 30 minutes at room temp.
7. PBS rinse three times for 5 minutes each.
8. Apply avidin-biotin complex (ABC) solution for 30-45 minutes. Be sure to mix the
ABC solution 30 minutes in advance.
9. PBS rinse three times for 5 minutes each.
10. Develop tissue sections in freshly mixed DAB substrate solution for 30-60 seconds.
11. Immediate PBS rinse three times for 5 minutes each.
12. Dehydrate through graded alcohols:
70% EtOH 5 minute
80% EtOH 5 minute
95% EtOH 5 minute
100% EtOH 5 minute 2X
xylene 5 minutes 2X
13. Coverslip with Permount.
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APPENDIX A13: IMAGE CAPTURE AND ANALYSIS
COMPUTER SETUP:
I. Go to the apple menu under 'Control Panels' select 'MODE32'.
MODE32 is enabled.
Make sure that
2. Go to the apple menu, under 'Control Panels' select 'Memory'. 32 Bit Addressing
should be on.
3. Go to the apple menu, under 'Control Panels' select 'Monitors'. Set colors to millions.
4. Restart the computer if any changes were made.
MICROSCOPE SETUP:
1. Turn the microscope on (green button on the right side).
2. Select the white button (max) for light level (on right side of the scope, there are 3
choices)
3. Locate the two knobs on the top portion of the microscope , one on the
the right. Pull both knobs out to the TV position.
left and one on
VIDEO BOX SETUP:
1. Turn the video box on. Watch the video level on the box at all times to make sure the
'Normal' indicator light is on. If the 'Over' light is on, there is too much light and it can
damage the computer screen. If the 'Over' light comes on, adjust the light level of the
microscope accordingly.
IMAGE CAPTURING:
1. Open the 'Tsunami' drive. Open the 'Applications' folder. Open the July version of
DIGIT.
2. Find the tissue on the microscope at the appropriate magnification.
3. Select 'Grab Live Video' from the 'View" menu.
4. Select 'Full Size' and then 'Grab Frames'.
5. Select images which contain a sufficient number of myelinated axons (or pores) for
analysis.
6. For each image captured, remember to 'Save' the file. Each time 'Close' the document
and select a 'New' document.
IMAGE ANALYSIS:
1. Open NIH Image.
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2. Open the captured image graphic file and save immediately using the NIH format.
3. Go to the 'Analyze' menu and select 'Set Scale'. Select micrometers as the unit of
measure. Use the following table to fill in the 'Known Distance' and the 'Pixels' entries.
(This table is calibrated for the microscope at the Brigham). When the scale is set, a
diamond appears next to the file name on the top bar of the window.
Magnification
4
10
20
40
100
Known Distance
4.15
1.66
0.83
0.415
0.166
4. Use 'Smooth' and/or 'Sharpen' from the 'Enhance' menu to improve the quality of the
image if needed. If you do not like the effect of these, choose 'Undo' from the 'Edit' menu
before proceeding.
5. From the 'Enhance' menu, choose 'Arithmetic Subtract'. Subtract 3.
6. From the 'Options' menu, select 'Density Slice'. By dragging the border of the red
color on the color scale with the mouse, threshold al the way to black so that no red is
showing in the image.
7. Select the ink dropper from the toolbar. Select the red color from the small portion of
red remaining in the color scale. Once red has been selected, select the pencil from the
toolbar.
8. Circle the axons (or pores) with the pencil along the OUTSIDE perimeter of the myelin
sheath.
9. When all axons have been circled, go to the 'Analyze' menu and select the 'Options'.
Chose 'Area', 'Perimeter/Length', and 'Headings'.
10. Use 'Save As' to save the image as an edited file. The image must be saved at this
point to retain the meaningful information.
11. In the 'Analyze' menu, choose
Minimum particle size:
Maximum particle size:
Label
Outline
Include Interior Holes
Reset
'Analyze Particles'. Enter the following:
5 pixels
30000 pixels
12. Print the analyzed image if desired.
13. Choose 'Show Results' from the 'Analyze' menu. Copy the results and paste into
Excel for analysis.
14. Close the image. Do not save the changes to your edited file!
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Pixels
1
1
1
1
1
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